@NP	Olfactory ensheathing cells	1
@NP	collateral	37
@NP	the injured adult rat spinal cord M.I.	68
@NP	Chuah , * D.	107
@NP	Chuah	107
@NP	* D.	113
@NP	Choi-Lundberg , S.	118
@NP	Choi-Lundberg	118
@NP	S.	133
@NP	Weston , A.J.	136
@NP	Weston	136
@NP	A.J.	144
@NP	Vincent , R.S.	149
@NP	Vincent	149
@NP	R.S.	158
@NP	Chung , J.C.	163
@NP	Chung	163
@NP	J.C.	170
@NP	Vickers , and A.K.	175
@NP	Vickers	175
@NP	A.K.	188
@NP	West NeuroRepair Group	193
@NP	School of Medicine , University of Tasmania , Hobart , Tasmania 7001 , Australia	217
@NP	School	217
@NP	Medicine , University of Tasmania , Hobart , Tasmania 7001 , Australia	227
@NP	Medicine , University	227
@NP	Tasmania , Hobart , Tasmania 7001 , Australia	251
@NP	Tasmania , Hobart , Tasmania 7001	251
@NP	Australia	284
@NP	13 February 2003	303
@NP	13	303
@NP	February 2003	306
@NP	20	329
@NP	August 2003	332
@NP	16 September 2003 Abstract	354
@NP	recent years	386
@NP	injection of olfactory ensheathing cells -LRB- ECs -RRB- into the spinal cord	400
@NP	injection	400
@NP	olfactory ensheathing cells -LRB- ECs -RRB- into the spinal cord	413
@NP	olfactory ensheathing cells -LRB- ECs -RRB-	413
@NP	olfactory ensheathing cells	413
@NP	ECs	442
@NP	the spinal cord	452
@NP	an experimental strategy	485
@NP	regeneration of injured axons	521
@NP	regeneration	521
@NP	injured axons	537
@NP	this study	555
@NP	we	567
@NP	the effects	584
@NP	ECs	626
@NP	those injected directly into the spinal cord	635
@NP	those	635
@NP	the spinal cord	664
@NP	The dorsal columns of adult rats	681
@NP	The dorsal columns	681
@NP	adult rats	703
@NP	T8	726
@NP	9 and rats in experimental groups	729
@NP	9	729
@NP	rats in experimental groups	735
@NP	rats	735
@NP	experimental groups	743
@NP	either EC-filled porous polymer capsules or culture medium -LRB- CM -RRB-	772
@NP	either EC-filled porous polymer capsules or culture medium	772
@NP	EC-filled porous polymer capsules	779
@NP	culture medium	816
@NP	CM	832
@NP	capsules	843
@NP	ECs injected at the injury site	857
@NP	ECs	857
@NP	the injury site	873
@NP	Control rats	890
@NP	three groups	911
@NP	uninjured	929
@NP	, -LRB- 2 -RRB- lesion with transplantation of CM-filled capsules	938
@NP	-LRB- 2 -RRB- lesion with transplantation	940
@NP	-LRB- 2 -RRB- lesion with	940
@NP	lesion	944
@NP	CM-filled	975
@NP	-LRB- 3 -RRB- lesion with transplantation	998
@NP	lesion	1002
@NP	transplantation	1014
@NP	CM-filled capsules and injections	1033
@NP	CM	1070
@NP	Three weeks	1074
@NP	injury	1092
@NP	Fluororuby	1100
@NP	the hindlimb motor and somatosensory cortex	1129
@NP	corticospinal neurons	1182
@NP	Observations	1205
@NP	there	1233
@NP	a few regenerating fibres , up to 10 , in the EC-treated groups	1244
@NP	a few regenerating fibres , up to 10 ,	1244
@NP	a few regenerating fibres	1244
@NP	10	1277
@NP	the EC-treated groups	1284
@NP	rats that received encapsulated ECs	1310
@NP	rats	1310
@NP	ECs	1342
@NP	regenerating fibres	1347
@NP	close association	1383
@NP	the capsule	1406
@NP	Rats	1419
@NP	EC injections	1438
@NP	a significant increase	1465
@NP	the number of collateral branches	1491
@NP	the number	1491
@NP	collateral branches	1505
@NP	the intact ventral corticospinal tract -LRB- vCST -RRB-	1530
@NP	the intact ventral corticospinal tract	1530
@NP	vCST	1570
@NP	the corresponding control , CM-injected group -LRB- P = 0.003 -RRB-	1590
@NP	the corresponding control	1590
@NP	CM-injected group -LRB- P = 0.003 -RRB-	1617
@NP	CM-injected group	1617
@NP	P	1637
@NP	0.003	1641
@NP	a trend for increased collateral branches	1655
@NP	a trend	1655
@NP	increased collateral branches	1667
@NP	rats that received	1713
@NP	rats	1713
@NP	ECs -LRB- P = 0.07 -RRB-	1745
@NP	ECs	1745
@NP	P	1751
@NP	0.07	1755
@NP	Introduction Traumatic injury to the spinal cord	1763
@NP	Introduction Traumatic injury	1763
@NP	the spinal cord	1796
@NP	a series	1821
@NP	cellular reactions	1833
@NP	functional deficits	1886
@NP	e.g. , reviews by Fawcett and Asher , 1999 ; Schwab and Bartholdi , 1996	1907
@NP	e.g. , reviews by Fawcett and Asher	1907
@NP	e.g.	1907
@NP	reviews by Fawcett and Asher	1913
@NP	reviews	1913
@NP	Fawcett and Asher	1924
@NP	1999 ; Schwab	1943
@NP	1999	1943
@NP	Schwab	1949
@NP	Bartholdi , 1996	1960
@NP	Bartholdi	1960
@NP	1996	1971
@NP	the first few days of injury	1985
@NP	the first few days	1985
@NP	injury	2007
@NP	there	2015
@NP	massive neuronal and glial cell death -LRB- Emery et al. , 1998 -RRB-	2024
@NP	massive neuronal and glial cell death	2024
@NP	Emery	2063
@NP	et al. , 1998	2069
@NP	et al.	2069
@NP	1998	2077
@NP	Axons distal to the injury site	2084
@NP	Axons	2084
@NP	the injury site	2100
@NP	reactive astrocytes	2133
@NP	scar tissue	2168
@NP	subsequent axonal regrowth	2196
@NP	a combination of mechanical and trophic mechanisms -LRB- Lindsay , 1986 -RRB-	2226
@NP	a combination	2226
@NP	mechanical and trophic mechanisms -LRB- Lindsay , 1986 -RRB-	2243
@NP	mechanical and trophic mechanisms	2243
@NP	Lindsay	2278
@NP	1986	2287
@NP	The injury site	2294
@NP	a complex environment	2313
@NP	reactive astrocytes	2346
@NP	fibroblasts	2367
@NP	immune cells	2380
@NP	a mix of growth factors , inhibitory factors , cytokines and other agents	2397
@NP	a mix	2397
@NP	growth factors , inhibitory factors , cytokines and other agents	2406
@NP	growth factors	2406
@NP	inhibitory factors	2422
@NP	cytokines	2442
@NP	other agents	2456
@NP	some	2470
@NP	some	2487
@NP	the surface of specific cells -LRB- Schwab and Bartholdi , 1996 -RRB-	2508
@NP	the surface	2508
@NP	specific cells -LRB- Schwab and Bartholdi , 1996 -RRB-	2523
@NP	specific cells	2523
@NP	Schwab and Bartholdi	2539
@NP	1996	2561
@NP	light of the restrictive nature of the injured central nervous system	2571
@NP	light	2571
@NP	the restrictive nature of the injured central nervous system	2580
@NP	the restrictive nature	2580
@NP	the injured central nervous system	2606
@NP	various experimental strategies	2642
@NP	this environment	2703
@NP	axonal repair	2728
@NP	place	2751
@NP	One of these	2758
@NP	One	2758
@NP	these	2765
@NP	the use of olfactory ensheathing cells -LRB- ECs -RRB-	2774
@NP	the use	2774
@NP	olfactory ensheathing cells -LRB- ECs -RRB-	2785
@NP	olfactory ensheathing cells	2785
@NP	ECs	2814
@NP	ECs	2828
@NP	the injured spinal cord	2846
@NP	a remarkable degree	2887
@NP	axonal regeneration and functional recovery	2910
@NP	regeneration	2917
@NP	e.g. , Imaizumi et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al. , 1998	2955
@NP	e.g.	2955
@NP	Imaizumi et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al.	2961
@NP	Imaizumi	2961
@NP	et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al.	2970
@NP	et al. , 1998	2970
@NP	et al.	2970
@NP	1998	2978
@NP	Nash et al. , 2002	2984
@NP	Nash	2984
@NP	et al. , 2002	2989
@NP	et al.	2989
@NP	2002	2997
@NP	Ramon-Cueto et al.	3003
@NP	Ramon-Cueto	3003
@NP	et al.	3015
@NP	1998	3023
@NP	remyelination	3040
@NP	axons -LRB- Li et al. , 1997 ; Imaizumi et al. , 1998 -RRB-	3070
@NP	axons	3070
@NP	Li	3077
@NP	et al. , 1997 ; Imaizumi et al. , 1998	3080
@NP	et al.	3080
@NP	1997 ; Imaizumi et al.	3088
@NP	1997	3088
@NP	Imaizumi et al.	3094
@NP	Imaizumi	3094
@NP	et al.	3103
@NP	1998	3111
@NP	the restoration	3145
@NP	ability	3173
@NP	rats	3184
@NP	spinal cords	3195
@NP	complete transection	3223
@NP	Ramon-Cueto	3245
@NP	et al. , 2000	3257
@NP	et al.	3257
@NP	2000	3265
@NP	studies	3281
@NP	the mechanisms	3313
@NP	ECs	3342
@NP	the novel environment of the injured spinal cord	3357
@NP	the novel environment	3357
@NP	the injured spinal cord	3382
@NP	Results of in vitro studies	3407
@NP	Results	3407
@NP	studies	3427
@NP	ECs	3458
@NP	cell surface molecules	3470
@NP	N-CAM , N-cadherin and laminin	3501
@NP	Chuah and Au , 1994 ; Chuah et al. , 1991 ; Treloar et al. , 1996	3532
@NP	Chuah and Au	3532
@NP	1994 ; Chuah et al. , 1991 ; Treloar et al.	3546
@NP	1994	3546
@NP	Chuah et al. , 1991 ; Treloar et al.	3552
@NP	Chuah	3552
@NP	et al. , 1991 ; Treloar et al.	3558
@NP	et al. , 1991	3558
@NP	et al.	3558
@NP	1991	3566
@NP	Treloar et al.	3572
@NP	Treloar	3572
@NP	et al.	3580
@NP	1996	3588
@NP	They	3595
@NP	many growth factors	3613
@NP	several forms	3643
@NP	neuregulins	3660
@NP	some neurotrophins	3676
@NP	Chuah and West , 2002 ; Chuah et al. , 2000 ; Woodhall et al. , 2001	3696
@NP	Chuah and West	3696
@NP	2002 ; Chuah et al. , 2000 ; Woodhall et al.	3712
@NP	2002	3712
@NP	Chuah et al. , 2000 ; Woodhall et al.	3718
@NP	Chuah	3718
@NP	et al. , 2000 ; Woodhall et al.	3724
@NP	et al. , 2000	3724
@NP	et al.	3724
@NP	2000	3732
@NP	Woodhall et al.	3738
@NP	Woodhall	3738
@NP	et al.	3747
@NP	2001	3755
@NP	It	3762
@NP	the reparative properties of ECs in the spinal cord	3786
@NP	the reparative properties	3786
@NP	ECs in the spinal cord	3815
@NP	ECs	3815
@NP	the spinal cord	3822
@NP	these soluble growth factors	3859
@NP	direct contact between ECs and host tissue	3899
@NP	direct contact	3899
@NP	ECs and host tissue	3922
@NP	spinal cord repair	3957
@NP	the present study	3980
@NP	we	3999
@NP	the effect	4016
@NP	ECs	4043
@NP	that of ECs injected directly into the injured spinal cord	4052
@NP	that	4052
@NP	ECs injected directly into the injured spinal cord	4060
@NP	ECs	4060
@NP	the injured spinal cord	4087
@NP	The dorsal corticospinal tract -LRB- dCST -RRB-	4112
@NP	The dorsal corticospinal tract	4112
@NP	dCST	4144
@NP	T8	4161
@NP	9 and the extent of repair	4164
@NP	9	4164
@NP	the extent of repair	4170
@NP	the extent	4170
@NP	repair	4184
@NP	segments of the spinal cord rostral and caudal	4250
@NP	segments	4250
@NP	the spinal cord rostral and caudal	4262
@NP	the spinal cord rostral	4262
@NP	caudal	4290
@NP	the lesion	4300
@NP	We	4312
@NP	the response of the uninjured ventral corticospinal tract -LRB- vCST -RRB-	4338
@NP	the response	4338
@NP	the uninjured ventral corticospinal tract -LRB- vCST -RRB-	4354
@NP	the uninjured ventral corticospinal tract	4354
@NP	vCST	4397
@NP	ECs that are encapsulated or implanted directly into the spinal cord	4406
@NP	ECs	4406
@NP	the spinal cord	4459
@NP	our knowledge	4479
@NP	this	4494
@NP	the influence of ECs	4529
@NP	the influence	4529
@NP	ECs	4546
@NP	collateral sprouting in the spinal cord	4553
@NP	collateral	4553
@NP	the spinal cord	4577
@NP	Materials and methods All procedures involving animals	4595
@NP	Materials and methods All procedures	4595
@NP	Materials	4595
@NP	methods All procedures	4609
@NP	methods	4609
@NP	All procedures	4617
@NP	animals	4642
@NP	the Animal Experimentation	4667
@NP	Ethics Committee of the University of Tasmania	4694
@NP	Ethics Committee	4694
@NP	the University of Tasmania	4714
@NP	the University	4714
@NP	Tasmania	4732
@NP	the Australian Code of Practice for the Care and Use of Animals	4765
@NP	the Australian Code	4765
@NP	Practice for the Care and Use of Animals	4788
@NP	Practice	4788
@NP	the Care and Use	4801
@NP	Animals	4821
@NP	Scientific Purposes	4833
@NP	Ensheathing cell purification and encapsulation Ensheathing cells	4854
@NP	Ensheathing cell purification	4854
@NP	encapsulation Ensheathing cells	4888
@NP	the basis of the method of Chuah and Teague -LRB- 1999 -RRB-	4950
@NP	the basis	4950
@NP	the method of Chuah and Teague -LRB- 1999 -RRB-	4963
@NP	the method	4963
@NP	Chuah and Teague	4977
@NP	1999	4995
@NP	modifications -LRB- Vincent et al. , 2003 -RRB-	5006
@NP	modifications	5006
@NP	Vincent	5021
@NP	et al. , 2003	5029
@NP	et al.	5029
@NP	2003	5037
@NP	the yield of ECs	5055
@NP	the yield	5055
@NP	ECs	5068
@NP	a high level of purity	5090
@NP	a high level	5090
@NP	purity	5106
@NP	The olfactory nerve layer -LRB- ONL -RRB- and mucosa -LRB- OM -RRB-	5114
@NP	The olfactory nerve layer -LRB- ONL -RRB-	5114
@NP	The olfactory nerve layer	5114
@NP	ONL	5141
@NP	mucosa -LRB- OM -RRB-	5150
@NP	mucosa	5150
@NP	OM	5158
@NP	3-day-old hooded Wistar rats euthanised in ice	5181
@NP	3-day-old hooded Wistar rats	5181
@NP	ice	5224
@NP	The ONL	5229
@NP	the glomerular and deeper layers of the olfactory bulb	5258
@NP	the glomerular and deeper layers	5258
@NP	the olfactory bulb	5294
@NP	the OM	5317
@NP	both sides of the nasal septum	5341
@NP	both sides	5341
@NP	the nasal septum	5355
@NP	the surrounding respiratory tissue	5391
@NP	The pooled tissues	5427
@NP	MEM HEPES modification -LRB- MEMH ; Sigma , NSW , Australia -RRB-	5463
@NP	MEM HEPES modification	5463
@NP	MEMH ; Sigma , NSW , Australia	5487
@NP	MEMH	5487
@NP	Sigma , NSW , Australia	5493
@NP	0.25 % trypsin -LRB- Gibco , NY -RRB- and 0.03 % collagenase -LRB- Sigma -RRB-	5527
@NP	0.25 % trypsin -LRB- Gibco , NY -RRB-	5527
@NP	0.25 % trypsin	5527
@NP	Gibco	5542
@NP	NY	5549
@NP	0.03 % collagenase -LRB- Sigma -RRB-	5557
@NP	0.03 % collagenase	5557
@NP	Sigma	5576
@NP	15 min at 37jC	5587
@NP	15 min	5587
@NP	37jC	5597
@NP	This incubation	5603
@NP	fresh solution	5643
@NP	culture medium	5678
@NP	CM	5694
@NP	MEM D-valine modification	5710
@NP	Sigma	5737
@NP	10 % dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB-	5762
@NP	10 %	5762
@NP	dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB-	5766
@NP	dialysed fetal calf serum	5766
@NP	10000 MW	5793
@NP	cut-off ; Sigma	5802
@NP	cut-off	5802
@NP	Sigma	5811
@NP	penicillin -- streptomycin	5822
@NP	penicillin	5822
@NP	streptomycin	5833
@NP	amphotericin B -LRB- Gibco -RRB- -LRB- Tisay and Key , 1999 -RRB-	5846
@NP	amphotericin B -LRB- Gibco -RRB-	5846
@NP	amphotericin B	5846
@NP	Gibco	5862
@NP	Tisay and Key	5870
@NP	1999	5885
@NP	The digested tissue	5892
@NP	a sterile nylon gauze -LRB- 80 Am pore size -RRB-	5945
@NP	a sterile nylon gauze	5945
@NP	80	5968
@NP	pore size	5974
@NP	10 min at 500 x g.	6005
@NP	10 min	6005
@NP	500 x g.	6015
@NP	500 x	6015
@NP	Resuspended cells	6024
@NP	CM	6057
@NP	24 h	6067
@NP	the culture	6073
@NP	10-4 M cytosine-β-D-arabinofuranoside -LRB- AraC ; Sigma -RRB- for 48 h	6102
@NP	10-4 M cytosine-β-D-arabinofuranoside -LRB- AraC ; Sigma -RRB-	6102
@NP	10-4 M cytosine-β-D-arabinofuranoside	6102
@NP	AraC ; Sigma	6141
@NP	AraC	6141
@NP	Sigma	6147
@NP	48 h	6158
@NP	the population of fibroblasts	6175
@NP	the population	6175
@NP	fibroblasts	6193
@NP	ECs	6215
@NP	125 µg/ml bovine pituitary extract -LRB- Sigma -RRB-	6236
@NP	125 µg/ml bovine pituitary extract	6236
@NP	Sigma	6272
@NP	2 days	6283
@NP	passage	6297
@NP	encapsulation	6310
@NP	ECs	6325
@NP	25-cm2 flasks -LRB- Sarstedt , NC -RRB-	6347
@NP	25-cm2 flasks	6347
@NP	Sarstedt	6362
@NP	NC	6372
@NP	500 x g	6392
@NP	500	6392
@NP	g	6398
@NP	CM	6419
@NP	means of a Hamilton syringe	6426
@NP	means	6426
@NP	a Hamilton syringe	6435
@NP	they	6455
@NP	a polyvinylidene fluoride -LRB- PVDF -RRB- hollow fibre of 1.0	6481
@NP	a polyvinylidene fluoride -LRB- PVDF -RRB- hollow fibre	6481
@NP	1.0	6530
@NP	mm diameter with a MW cut-off of 300 000 Da -LRB- Spectrum , CA -RRB-	6535
@NP	mm diameter	6535
@NP	a MW cut-off of 300 000 Da -LRB- Spectrum , CA -RRB-	6552
@NP	a MW cut-off of 300 000 Da	6552
@NP	300 000	6568
@NP	Spectrum	6580
@NP	CA	6590
@NP	each end of the fibre	6610
@NP	each end	6610
@NP	the fibre	6622
@NP	heat	6636
@NP	a capsule	6656
@NP	6 -- 8 mm long	6676
@NP	6	6676
@NP	8 mm	6678
@NP	105 ECs	6709
@NP	Control capsules	6718
@NP	CM	6745
@NP	no ECs	6759
@NP	All capsules	6767
@NP	CM overnight at 37 °C in 5 % carbon dioxide	6795
@NP	CM overnight	6795
@NP	37 °C in 5 % carbon dioxide	6811
@NP	37 °C	6811
@NP	5 % carbon dioxide	6819
@NP	the spinal cord	6861
@NP	the following day	6877
@NP	Hoechst blue-labeling of ensheathing cells	6896
@NP	Hoechst blue-labeling	6896
@NP	ensheathing cells	6921
@NP	Ensheathing cells	6939
@NP	direct injections	6976
@NP	the spinal cord were prelabeled with Hoechst 33342	6999
@NP	the spinal cord	6999
@NP	Hoechst 33342	7036
@NP	Sigma	7051
@NP	One day	7059
@NP	injection	7074
@NP	ECs that were growing in a 25-cm2 flask	7085
@NP	ECs	7085
@NP	a 25-cm2 flask	7110
@NP	10 ng/ml	7143
@NP	Hoechst 33342	7152
@NP	CM	7169
@NP	a stock of 10 mg/ml in dimethyl sulfoxide	7189
@NP	a stock	7189
@NP	10 mg/ml in dimethyl sulfoxide	7200
@NP	10 mg/ml	7200
@NP	dimethyl sulfoxide	7212
@NP	The cells	7232
@NP	40 min at 37 °C	7261
@NP	40 min	7261
@NP	37 °C	7271
@NP	four times	7284
@NP	MEMH	7298
@NP	fresh CM	7319
@NP	A small sample of cells	7329
@NP	A small sample	7329
@NP	cells	7347
@NP	the flask	7369
@NP	ultraviolet filter	7396
@NP	the staining	7429
@NP	implantation	7470
@NP	the CM	7484
@NP	any unincorporated Hoechst	7521
@NP	the solution	7568
@NP	A fresh flask of unlabeled cells	7582
@NP	A fresh flask	7582
@NP	unlabeled cells	7599
@NP	overnight with this medium	7629
@NP	overnight	7629
@NP	this medium	7644
@NP	ultraviolet filter	7674
@NP	Only labeling of a barely detectable level	7694
@NP	Only labeling	7694
@NP	a barely detectable level	7711
@NP	This procedure	7751
@NP	a precautionary measure	7778
@NP	host tissues	7820
@NP	excess	7853
@NP	solution	7867
@NP	the process of injecting ECs into the spinal cord	7883
@NP	the process	7883
@NP	ECs	7908
@NP	the spinal cord	7917
@NP	Thirty minutes	7934
@NP	injection	7956
@NP	ECs	7967
@NP	half the flask	7989
@NP	500 x g	8020
@NP	500	8020
@NP	g	8026
@NP	a concentration of about 104 cells/µl CM	8047
@NP	a concentration	8047
@NP	104 cells/µl CM	8072
@NP	Spinal lesion surgeries Adult rats	8089
@NP	Spinal lesion surgeries	8089
@NP	Adult rats	8113
@NP	270	8133
@NP	380 g	8137
@NP	3 % isoflurane with oxygen	8167
@NP	3 % isoflurane	8167
@NP	oxygen	8186
@NP	2 -- 2.5 % isoflurane with oxygen	8212
@NP	2	8212
@NP	2.5 % isoflurane with oxygen	8214
@NP	2.5 % isoflurane	8214
@NP	oxygen	8235
@NP	0.5 l/min	8245
@NP	the surgery	8266
@NP	Rats	8279
@NP	0.1 ml/kg Rimadyl	8318
@NP	carprofen 50 mg/ml	8337
@NP	a nonsteroidal anti-inflammatory	8357
@NP	analgesic ; Pfizer Animal Health , UK	8394
@NP	analgesic	8394
@NP	Pfizer Animal Health , UK	8405
@NP	Pfizer Animal Health	8405
@NP	UK	8427
@NP	0.1 ml/kg Norocillin L.A.	8453
@NP	procaine penicillin G	8480
@NP	150 mg/ml	8502
@NP	benzathine penicillin	8516
@NP	112.5 mg/ml ; Norbrook Laboratories , UK	8540
@NP	112.5 mg/ml	8540
@NP	Norbrook Laboratories , UK	8553
@NP	Norbrook Laboratories	8553
@NP	UK	8576
@NP	40 ml/kg Hartmann 's saline	8607
@NP	40 ml/kg	8607
@NP	Hartmann 's saline	8616
@NP	Hartmann 's	8616
@NP	0.9 % saline -LRB- Baxter Healthcare , NSW , Australia -RRB-	8637
@NP	0.9 % saline	8637
@NP	Baxter Healthcare	8650
@NP	NSW	8669
@NP	Australia	8674
@NP	Hair from the back	8686
@NP	Hair	8686
@NP	the back	8696
@NP	clippers	8722
@NP	skin	8735
@NP	70 % ethanol and povidone-iodine	8753
@NP	A sterile surgical drape	8786
@NP	the rat and the skin	8827
@NP	the rat	8827
@NP	the skin	8839
@NP	spinous processes	8853
@NP	thoracic vertebrae 6 -- 11 -LRB- T6 -- T11 -RRB- was incised and retracted	8874
@NP	thoracic vertebrae	8874
@NP	6 -- 11 -LRB- T6 -- T11 -RRB-	8893
@NP	6 -- 11	8893
@NP	T6 -- T11	8899
@NP	T6	8899
@NP	T11	8903
@NP	Attachments of muscles to T7	8935
@NP	Attachments	8935
@NP	muscles to T7	8950
@NP	muscles	8950
@NP	T7	8961
@NP	T10 spinous processes were cut and the muscles retracted	8964
@NP	T10	8964
@NP	spinous processes	8968
@NP	the muscles	8999
@NP	The spinous processes of T8 and T9	9022
@NP	The spinous processes	9022
@NP	T8 and T9	9047
@NP	rongeurs	9075
@NP	a laminectomy	9088
@NP	a dental drill and rongeurs	9118
@NP	the dorsal spinal cord	9156
@NP	The dura	9180
@NP	microscissors	9206
@NP	The dorsal columns , which include the dCST ,	9221
@NP	The dorsal columns	9221
@NP	the dCST	9255
@NP	microscissors	9286
@NP	a stereotaxic arm	9312
@NP	a depth of 1.5 mm	9333
@NP	a depth	9333
@NP	1.5 mm	9344
@NP	the dorsal surface of the spinal cord	9357
@NP	the dorsal surface	9357
@NP	the spinal cord	9379
@NP	The width of the cut	9414
@NP	The width	9414
@NP	the cut	9427
@NP	1.5 -- 2.0 mm , centred on the midline	9439
@NP	1.5	9439
@NP	2.0 mm , centred on the midline	9443
@NP	2.0 mm	9443
@NP	the midline	9462
@NP	Experimental trials	9475
@NP	this surgical procedure	9529
@NP	a consistent total transection of the dCST	9562
@NP	a consistent total transection	9562
@NP	the dCST	9596
@NP	both sides	9608
@NP	Two groups of rats	9620
@NP	Two groups	9620
@NP	rats	9634
@NP	injections of ECs -LRB- n = 6 -RRB- or CM -LRB- n = 5 -RRB-	9648
@NP	injections	9648
@NP	ECs -LRB- n = 6 -RRB- or CM -LRB- n = 5 -RRB-	9662
@NP	ECs	9662
@NP	n	9667
@NP	6	9671
@NP	CM	9677
@NP	n	9681
@NP	5	9685
@NP	placement of a CM-containing PVDF capsule during the same lesion surgery	9700
@NP	placement	9700
@NP	a CM-containing PVDF capsule during the same lesion surgery	9713
@NP	a CM-containing PVDF capsule	9713
@NP	the same lesion surgery	9749
@NP	ECs suspended in CM or CM	9774
@NP	ECs	9774
@NP	CM or CM	9791
@NP	a 10-Al syringe	9823
@NP	26-s gauge	9844
@NP	needle -LRB- Hamilton , Reno , NV -RRB-	9864
@NP	needle	9864
@NP	Hamilton	9872
@NP	Reno	9882
@NP	NV	9888
@NP	the `` fast up '' function	9898
@NP	fast up	9904
@NP	an sp310i syringe pump	9926
@NP	World Precision Instruments , Victoria , Australia	9950
@NP	World Precision Instruments , Victoria	9950
@NP	Australia	9989
@NP	a stereotaxic frame	10011
@NP	One microlitre of ECs or CM	10032
@NP	One microlitre	10032
@NP	ECs or CM	10050
@NP	the pump	10078
@NP	an injection rate of 1 µl/min	10094
@NP	an injection rate	10094
@NP	1 µl/min	10115
@NP	each of four sites	10127
@NP	each	10127
@NP	four sites	10135
@NP	0.3 mm to the right	10147
@NP	0.3 mm	10147
@NP	the right	10157
@NP	left of the midline and 2 -- 3 mm anterior and posterior	10171
@NP	left of the midline and 2	10171
@NP	left	10171
@NP	the midline and 2	10179
@NP	the midline	10179
@NP	2	10195
@NP	3 mm anterior and posterior	10197
@NP	3 mm	10197
@NP	the injury site	10228
@NP	All injections	10245
@NP	1.0 mm	10265
@NP	the dorsal surface of the spinal cord	10280
@NP	the dorsal surface	10280
@NP	the spinal cord	10302
@NP	These	10319
@NP	the injected material	10360
@NP	the dCST	10398
@NP	4 µl of ECs or CM	10422
@NP	4 µl	10422
@NP	ECs or CM	10430
@NP	1 µl/min at the injury site	10456
@NP	1 µl/min	10456
@NP	the injury site	10468
@NP	the midline	10487
@NP	each of the five injections	10506
@NP	each	10506
@NP	the five injections	10514
@NP	the needle	10535
@NP	place for 1 min	10558
@NP	place	10558
@NP	1 min	10568
@NP	the injections	10585
@NP	a PVDF fibre capsule filled with CM	10601
@NP	a PVDF fibre capsule	10601
@NP	CM	10634
@NP	the dorsal median sulcus	10655
@NP	the spinal cord	10683
@NP	the injury site	10729
@NP	Two additional groups of rats	10746
@NP	Two additional groups	10746
@NP	rats	10771
@NP	a PVDF fibre capsule	10785
@NP	ECs -LRB- n = 5 -RRB- or CM -LRB- n = 6 -RRB-	10818
@NP	ECs	10818
@NP	n	10823
@NP	5	10827
@NP	CM	10833
@NP	n	10837
@NP	6	10841
@NP	no injections of ECs or CM	10849
@NP	no injections	10849
@NP	ECs or CM	10866
@NP	the same lesion surgery	10884
@NP	The capsule	10909
@NP	the dorsal median sulcus	10939
@NP	the spinal cord	10967
@NP	the injury site	11013
@NP	the lesion	11040
@NP	injections -LRB- in two groups -RRB-	11052
@NP	injections	11052
@NP	two groups	11067
@NP	capsule placement -LRB- in all four groups -RRB-	11083
@NP	capsule placement	11083
@NP	all four groups	11105
@NP	the retracted muscles	11123
@NP	5	11163
@NP	0 silk and the skin	11165
@NP	0 silk	11165
@NP	the skin	11176
@NP	Michel wound clips	11197
@NP	The skin	11217
@NP	povidone-iodine	11243
@NP	the rat	11263
@NP	its individual home cage	11283
@NP	a heat lamp for 1 h.	11314
@NP	a heat lamp	11314
@NP	1 h.	11330
@NP	Rats	11335
@NP	3 days	11364
@NP	surgery subcutaneously with 0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	11381
@NP	surgery	11381
@NP	0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	11409
@NP	0.1 ml/kg Rimadyl	11409
@NP	carprofen 50 mg/ml	11428
@NP	carprofen	11428
@NP	50 mg/ml	11438
@NP	Cortical injections of Fluororuby	11449
@NP	Cortical injections	11449
@NP	Fluororuby	11472
@NP	the corticospinal tract	11506
@NP	rats	11531
@NP	Fluororuby -LRB- Molecular Probes , Eugene , OR -RRB-	11555
@NP	Fluororuby	11555
@NP	Molecular Probes	11567
@NP	Eugene	11585
@NP	OR	11593
@NP	the hindlimb motor and somatosensory cortex	11602
@NP	most corticospinal neurons	11662
@NP	the lumbosacral enlargement of the spinal cord	11703
@NP	the lumbosacral enlargement	11703
@NP	the spinal cord	11734
@NP	Li	11751
@NP	et al. , 1990	11754
@NP	et al.	11754
@NP	1990	11762
@NP	Fluororuby injections	11769
@NP	3 weeks	11806
@NP	spinal lesion surgeries	11820
@NP	a group of uninjured rats	11856
@NP	a group	11856
@NP	uninjured rats	11867
@NP	340 -- 365 g -LRB- n = 4 -RRB-	11891
@NP	340	11891
@NP	365 g -LRB- n = 4 -RRB-	11895
@NP	n	11902
@NP	4	11906
@NP	Rats	11910
@NP	Rimadyl , Norocillin L.A. and saline	11952
@NP	Rimadyl	11952
@NP	Norocillin L.A.	11961
@NP	saline	11981
@NP	the spinal surgeries	11995
@NP	They	12017
@NP	a stereotaxic frame	12037
@NP	gas anaesthesia mask -LRB- David Kopf Instruments , Tujunga , CA -RRB-	12062
@NP	gas anaesthesia mask	12062
@NP	David Kopf Instruments	12084
@NP	Tujunga	12108
@NP	CA	12117
@NP	Scalp hair	12122
@NP	clippers	12150
@NP	the scalp	12160
@NP	70 % ethanol and povidone-iodine	12183
@NP	Scalp flaps	12229
@NP	fascia	12260
@NP	the skull with cotton tip applicators	12280
@NP	the skull	12280
@NP	cotton tip applicators	12295
@NP	The bregma and lambda	12319
@NP	the horizontal plane	12358
@NP	the bite bar	12392
@NP	Burr holes	12406
@NP	the skull	12433
@NP	the injection sites at the following coordinates relative to the bregma	12449
@NP	the injection sites	12449
@NP	the following coordinates relative to the bregma	12472
@NP	the following	12472
@NP	the bregma	12510
@NP	0.9 mm posterior , 2.0 mm lateral	12522
@NP	0.9 mm posterior	12522
@NP	2.0 mm lateral	12540
@NP	1.9 mm posterior , 2.4 mm lateral	12556
@NP	1.9 mm posterior	12556
@NP	2.4 mm lateral	12574
@NP	2.9 mm posterior , 2.6 mm lateral , on both the right and left	12594
@NP	2.9 mm posterior , 2.6 mm lateral ,	12594
@NP	2.9 mm posterior	12594
@NP	2.6 mm lateral	12612
@NP	both the right and left	12631
@NP	the basis location of hindlimb somatosensory cortex	12671
@NP	the basis location	12671
@NP	hindlimb somatosensory cortex	12693
@NP	Paxinos and Watson , 1986	12726
@NP	Paxinos and Watson	12726
@NP	1986	12746
@NP	Half a microlitre of Fluororuby solution	12753
@NP	Half	12753
@NP	a microlitre of Fluororuby solution	12758
@NP	a microlitre	12758
@NP	Fluororuby solution	12774
@NP	10 % rhodamine -- dextran , MW 10 000 in water with 0.5 % Triton X100	12795
@NP	10 % rhodamine	12795
@NP	dextran , MW 10 000 in water with 0.5 % Triton X100	12809
@NP	dextran	12809
@NP	MW 10 000 in water with 0.5 % Triton X100	12818
@NP	water with 0.5 %	12831
@NP	water	12831
@NP	0.5 %	12842
@NP	each	12876
@NP	the six sites	12884
@NP	1.8 mm	12898
@NP	the dura	12911
@NP	a rate	12923
@NP	0.5 µl/min	12933
@NP	a 10 µl Hamilton syringe	12950
@NP	33 gauge needle controlled by an sp310i syringe pump	12980
@NP	33 gauge needle	12980
@NP	an sp310i syringe pump	13010
@NP	The needle	13034
@NP	place for 1 min	13057
@NP	place	13057
@NP	1 min	13067
@NP	each injection	13079
@NP	Burr holes	13095
@NP	bone wax	13123
@NP	the scalp	13136
@NP	suture clips	13158
@NP	The skin	13172
@NP	povidoneiodine	13198
@NP	the rat	13217
@NP	its individual home cage	13237
@NP	a heat lamp for 30 min	13268
@NP	a heat lamp	13268
@NP	30 min	13284
@NP	Rats	13292
@NP	2 days	13321
@NP	the surgery subcutaneously with 0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	13338
@NP	the surgery	13338
@NP	0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	13370
@NP	0.1 ml/kg Rimadyl	13370
@NP	carprofen 50 mg/ml	13389
@NP	carprofen	13389
@NP	50 mg/ml	13399
@NP	Histology Rats	13410
@NP	0.4 ml Nembutal -LRB- 200 mg / kg ; Boehringer Ingelheim , NSW , Australia -RRB-	13449
@NP	0.4 ml Nembutal	13449
@NP	200 mg	13466
@NP	kg ; Boehringer Ingelheim , NSW , Australia	13474
@NP	kg	13474
@NP	Boehringer Ingelheim , NSW , Australia	13478
@NP	2 weeks	13516
@NP	injection of Fluororuby	13530
@NP	injection	13530
@NP	Fluororuby	13543
@NP	They	13555
@NP	cold phosphate	13594
@NP	saline	13618
@NP	PBS	13626
@NP	4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13643
@NP	4 % paraformaldehyde	13643
@NP	0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13666
@NP	0.1 M phosphate buffer	13666
@NP	pH 7.4	13690
@NP	perfusion	13705
@NP	the vertebral column and attached brain	13716
@NP	the vertebral column	13716
@NP	attached brain	13741
@NP	cold 4 % buffered paraformaldehyde overnight	13785
@NP	cold	13785
@NP	paraformaldehyde overnight	13802
@NP	The following day	13830
@NP	the spinal cord	13849
@NP	bloc	13880
@NP	the rest of the vertebral column	13890
@NP	the rest	13890
@NP	the vertebral column	13902
@NP	segments	13936
@NP	levels indicated in Fig. 1A	13948
@NP	levels	13948
@NP	Fig. 1A	13968
@NP	The rostral ends of spinal cord segments	13977
@NP	The rostral ends	13977
@NP	spinal cord segments	13997
@NP	a solution of 15 % Alcian Blue in 50 % glycerol	14035
@NP	a solution	14035
@NP	15 % Alcian Blue in 50 % glycerol	14049
@NP	50 %	14068
@NP	orientation of specimens on the cryostat -LRB- Jung Frigocut 2800E , Leica -RRB-	14095
@NP	orientation	14095
@NP	specimens on the cryostat -LRB- Jung Frigocut 2800E , Leica -RRB-	14110
@NP	specimens	14110
@NP	the cryostat -LRB- Jung Frigocut 2800E , Leica -RRB-	14123
@NP	the cryostat	14123
@NP	Jung Frigocut 2800E , Leica	14137
@NP	Jung Frigocut 2800E	14137
@NP	Leica	14158
@NP	All segments	14166
@NP	4 % paraformaldehyde	14203
@NP	4 °C	14226
@NP	sectioning , at which time they were embedded in Tissue-TekR O.C.T.	14246
@NP	sectioning	14246
@NP	they	14272
@NP	Tissue-TekR O.C.T.	14294
@NP	ProSciTech	14323
@NP	QLD	14335
@NP	Australia	14340
@NP	The approximately 2.8-cm length of cord containing the capsule	14352
@NP	The approximately 2.8-cm length	14352
@NP	cord containing the capsule	14387
@NP	cord	14387
@NP	the capsule	14403
@NP	50	14430
@NP	thickness	14436
@NP	the sagittal plane	14450
@NP	all other sections	14475
@NP	the transverse plane	14507
@NP	the cervical , upper thoracic and midthoracic level	14531
@NP	the cervical	14531
@NP	upper thoracic and midthoracic level	14545
@NP	Sections	14583
@NP	water bath	14608
@NP	O.C.T. compound	14629
@NP	slides	14665
@NP	2 % 3-aminopropyltriethoxysilane	14684
@NP	acetone -LRB- Sigma -RRB- -LRB- Henderson , 1989 -RRB-	14719
@NP	acetone -LRB- Sigma -RRB-	14719
@NP	acetone	14719
@NP	Sigma	14728
@NP	Henderson	14736
@NP	1989	14747
@NP	It	14754
@NP	the sections	14783
@NP	the capsule	14810
@NP	the rest of the spinal cord tissue	14850
@NP	the rest	14850
@NP	the spinal cord tissue	14862
@NP	an oval-shaped space	14894
@NP	the spinal cord section	14918
@NP	Sections	14943
@NP	1 h in the dark	14976
@NP	1 h	14976
@NP	the dark	14983
@NP	DAKO	15015
@NP	fluorescent mounting medium	15020
@NP	evaporation	15060
@NP	sections	15086
@NP	nail polish	15096
@NP	the edges of coverslips	15125
@NP	the edges	15125
@NP	coverslips	15138
@NP	Histological examinations	15150
@NP	a fluorescence attachment	15196
@NP	an Olympus BX50 microscope	15233
@NP	images	15264
@NP	an Olympus DP50 digital camera with the aid of Viewfinder Lite and Studio Lite	15286
@NP	an Olympus DP50 digital camera	15286
@NP	the aid of Viewfinder Lite and Studio Lite	15322
@NP	the aid	15322
@NP	Viewfinder Lite and Studio Lite	15333
@NP	Viewfinder Lite	15333
@NP	Studio Lite	15353
@NP	1.0 software -LRB- Pixera Corporation -RRB-	15365
@NP	1.0 software	15365
@NP	Pixera Corporation	15379
@NP	the number of dCST fibres	15409
@NP	the number	15409
@NP	dCST fibres	15423
@NP	transverse sections	15438
@NP	images	15459
@NP	A4 size	15483
@NP	A plastic transparency	15504
@NP	the fluorescent tract	15543
@NP	individual axons	15569
@NP	a pen	15607
@NP	the counting	15616
@NP	Images of vCST at the lower thoracic level	15640
@NP	Images	15640
@NP	vCST at the lower thoracic level	15650
@NP	vCST	15650
@NP	the lower thoracic level	15658
@NP	a magnification of 450x	15722
@NP	a magnification	15722
@NP	450x	15741
@NP	sagittal sections	15750
@NP	an 8-mm length of the spinal cord caudal to the capsule	15769
@NP	an 8-mm length	15769
@NP	the spinal cord caudal to the capsule	15787
@NP	the spinal cord caudal	15787
@NP	the capsule	15813
@NP	the number of axonal branches	15847
@NP	the number	15847
@NP	axonal branches	15861
@NP	the vCST fibres	15882
@NP	All serial sagittal sections of each spinal cord segment	15899
@NP	All serial sagittal sections	15899
@NP	each spinal cord segment	15931
@NP	400 magnification	15973
@NP	the number	15997
@NP	fibres	16011
@NP	vCST fibres	16042
@NP	Fig. 4H	16092
@NP	the number of terminal branches of axons present in the grey matter	16125
@NP	the number	16125
@NP	terminal branches of axons present in the grey matter	16139
@NP	terminal branches	16139
@NP	axons present in the grey matter	16160
@NP	axons	16160
@NP	the grey matter	16177
@NP	Terminal branches	16211
@NP	an arborisation	16260
@NP	a single axon	16291
@NP	innervation	16323
@NP	the grey matter	16353
@NP	the uninjured animals	16373
@NP	counts	16396
@NP	the corresponding similar level	16421
@NP	All counts	16454
@NP	a person blinded to the treatment group	16483
@NP	a person	16483
@NP	the treatment group	16503
@NP	Statistical evaluation of counts and comparison among groups	16524
@NP	Statistical evaluation	16524
@NP	counts and comparison	16550
@NP	groups	16578
@NP	SigmaStat 2.03	16605
@NP	Jandel Scientific Software Corporation	16621
@NP	San Rafael	16661
@NP	CA	16673
@NP	the results presented in Figs. 6A and B.	16681
@NP	the results	16681
@NP	Figs. 6A and B.	16706
@NP	A one-way ANOVA	16722
@NP	differences	16760
@NP	groups , followed by multiple pair wise comparison -LRB- Tukey test -RRB-	16778
@NP	groups	16778
@NP	multiple pair wise comparison -LRB- Tukey test -RRB-	16798
@NP	multiple pair wise comparison	16798
@NP	Tukey test	16829
@NP	A P value of < 0.05	16842
@NP	A P value	16842
@NP	< 0.05	16855
@NP	<	16855
@NP	0.05	16857
@NP	data	16907
@NP	mean F SEM	16930
@NP	Results Fig. 1 .	16943
@NP	Results	16943
@NP	Fig. 1	16952
@NP	-LRB- A -RRB- Dissected brain and spinal cord of rat .	16960
@NP	-LRB- A -RRB-	16960
@NP	brain and spinal cord of rat	16974
@NP	brain and spinal cord	16974
@NP	rat	16999
@NP	Arrows	17004
@NP	the levels at which the spinal cord is cut into segments	17020
@NP	the levels	17020
@NP	the spinal cord	17040
@NP	segments	17068
@NP	Transverse sections -LRB- 50-µm thickness -RRB-	17078
@NP	Transverse sections	17078
@NP	50-µm thickness	17099
@NP	the cervical	17129
@NP	C	17143
@NP	upper thoracic -LRB- UT -RRB-	17147
@NP	mid-thoracic -LRB- MT -RRB-	17168
@NP	upper lumbar level	17190
@NP	the bracketed segment	17232
@NP	the	17232
@NP	segment	17246
@NP	The bracketed segment	17256
@NP	The	17256
@NP	segment	17270
@NP	the lesion	17287
@NP	Scale	17341
@NP	1.5 cm	17353
@NP	-LRB- B -RRB- Transverse section of the spinal cord at the mid-thoracic level	17361
@NP	-LRB- B -RRB- Transverse section	17361
@NP	B	17362
@NP	the spinal cord at the mid-thoracic level	17387
@NP	the spinal cord	17387
@NP	the mid-thoracic level	17406
@NP	the Fluororuby-labeled dorsal	17437
@NP	corticospinal tract	17467
@NP	Scale	17488
@NP	0.8 mm	17500
@NP	Inset	17508
@NP	a magnified image of the fibres of the vCST	17520
@NP	a magnified image	17520
@NP	the fibres of the vCST	17541
@NP	the fibres	17541
@NP	the vCST	17555
@NP	Scale	17565
@NP	200 µm	17577
@NP	Fig. 2 .	17586
@NP	Fig.	17586
@NP	2	17591
@NP	-LRB- A -RRB- Graphical presentation of the number of	17594
@NP	-LRB- A -RRB- Graphical presentation	17594
@NP	A	17595
@NP	the number of	17624
@NP	the number	17624
@NP	dorsal corticospinal fibres	17646
@NP	the cervical , upper and mid-thoracic level	17677
@NP	all groups	17723
@NP	The rats which received EC or CM injections also	17735
@NP	The rats	17735
@NP	EC or CM injections	17759
@NP	culture medium -LRB- CM -RRB-	17788
@NP	culture medium	17788
@NP	CM	17804
@NP	capsules placed over the lesion	17819
@NP	capsules	17819
@NP	the lesion	17840
@NP	There	17852
@NP	no statistically significant difference among the treatment groups	17862
@NP	no statistically significant difference	17862
@NP	the treatment groups	17908
@NP	-LRB- B -RRB-	17930
@NP	The number	17934
@NP	dorsal corticospinal fibres	17956
@NP	the upper and mid-thoracic levels	17987
@NP	a percentage of fibres	18034
@NP	a percentage	18034
@NP	fibres	18050
@NP	the cervical level within each group	18060
@NP	the cervical level	18060
@NP	each group	18086
@NP	the uninjured group	18109
@NP	all treatment groups	18130
@NP	a reduction	18158
@NP	the number of dorsal corticospinal fibres	18173
@NP	the number	18173
@NP	dorsal corticospinal fibres	18187
@NP	the cervical to the mid-thoracic level	18220
@NP	the cervical	18220
@NP	the mid-thoracic level	18236
@NP	The data	18260
@NP	many of the corticospinal neurons	18288
@NP	many	18288
@NP	the corticospinal neurons	18296
@NP	5 weeks	18336
@NP	Data	18357
@NP	mean ± SEM	18379
@NP	Fig. 3 .	18392
@NP	Fig.	18392
@NP	3	18397
@NP	Tracing	18400
@NP	a typical sagittal section	18411
@NP	the spinal cord	18441
@NP	the cavity	18465
@NP	the location of the capsule -LRB- * -RRB-	18488
@NP	the location	18488
@NP	the capsule -LRB- * -RRB-	18504
@NP	the capsule	18504
@NP	its spatial orientation with the dorsal corticospinal tract -LRB- dCST -RRB-	18524
@NP	its spatial orientation	18524
@NP	the dorsal corticospinal tract -LRB- dCST -RRB-	18553
@NP	the dorsal corticospinal tract	18553
@NP	dCST	18585
@NP	The grey matter	18592
@NP	the middle one-third of the section	18620
@NP	the middle one-third	18620
@NP	the section	18644
@NP	The labeled arrows	18657
@NP	the approximate locations	18685
@NP	Fig. 4	18722
@NP	R = rostral , C = caudal .	18742
@NP	R = rostral	18742
@NP	C = caudal	18755
@NP	Scale	18767
@NP	2.5 mm	18779
@NP	Fig. 4 .	18788
@NP	Fig.	18788
@NP	4	18793
@NP	Longitudinal sections of spinal cord segment	18796
@NP	Longitudinal sections	18796
@NP	spinal cord segment	18821
@NP	lesion and capsule , 2 weeks after injection of Fluororuby	18852
@NP	lesion and capsule	18852
@NP	2 weeks after injection of Fluororuby	18872
@NP	2 weeks	18872
@NP	injection of Fluororuby	18886
@NP	injection	18886
@NP	Fluororuby	18899
@NP	`` capsule ''	18911
@NP	the cavity which previously housed a capsule containing ECs	18929
@NP	the cavity	18929
@NP	a capsule	18964
@NP	ECs	18985
@NP	-LRB- A -RRB-	18990
@NP	post-lesion recovery	19001
@NP	the capsule	19023
@NP	the spinal cord	19067
@NP	the path of the	19104
@NP	the path	19104
@NP	the	19116
@NP	dorsal corticospinal tract	19130
@NP	Nerve sprouts projecting from the sides of the tract -LRB- asterisk -RRB-	19158
@NP	Nerve sprouts	19158
@NP	the sides of the tract -LRB- asterisk -RRB-	19188
@NP	the sides	19188
@NP	the tract -LRB- asterisk -RRB-	19201
@NP	the tract	19201
@NP	asterisk	19212
@NP	higher magnification	19237
@NP	Scale	19259
@NP	800 µm	19271
@NP	-LRB- B -RRB-	19279
@NP	Arrow	19283
@NP	a fibre sprouting from the dorsal corticospinal tract -LRB- dCST -RRB-	19299
@NP	a fibre	19299
@NP	the dorsal corticospinal tract -LRB- dCST -RRB-	19322
@NP	the dorsal corticospinal tract	19322
@NP	dCST	19354
@NP	the area marked by asterisk in A.	19363
@NP	the area	19363
@NP	asterisk in A.	19382
@NP	asterisk	19382
@NP	A.	19394
@NP	The fibre	19397
@NP	an arborisation of fine sprouts	19415
@NP	an arborisation	19415
@NP	fine sprouts	19434
@NP	Scale	19448
@NP	300 µm	19460
@NP	-LRB- C -RRB- Arrows	19468
@NP	two fine nerve fibres	19488
@NP	the tissue	19521
@NP	the EC-containing capsule	19542
@NP	Scale	19569
@NP	250 µm	19581
@NP	-LRB- D -RRB- Arrows	19589
@NP	a nerve fibre	19609
@NP	close	19631
@NP	the ventral edge of the capsule -LRB- C -RRB-	19640
@NP	the ventral edge	19640
@NP	the capsule -LRB- C -RRB-	19660
@NP	the capsule	19660
@NP	C	19673
@NP	ECs	19687
@NP	Scale	19692
@NP	700 µm	19704
@NP	-LRB- E -RRB-	19712
@NP	nerve fibres -LRB- arrows -RRB-	19729
@NP	nerve fibres	19729
@NP	arrows	19743
@NP	the EC-containing capsule	19768
@NP	its caudal edge	19810
@NP	the capsule and clusters of brightly fluorescent cells	19849
@NP	the capsule and clusters	19849
@NP	brightly fluorescent cells	19877
@NP	Scale	19929
@NP	180 µm	19941
@NP	-LRB- F -RRB- Section from spinal cord bearing lesion	19949
@NP	-LRB- F -RRB-	19949
@NP	spinal cord bearing lesion	19966
@NP	ECs	20007
@NP	capsule	20033
@NP	the culture medium	20052
@NP	A nerve fibre -LRB- arrows -RRB-	20072
@NP	A nerve fibre	20072
@NP	arrows	20087
@NP	the caudal edge of the capsule	20126
@NP	the caudal edge	20126
@NP	the capsule	20145
@NP	Scale	20158
@NP	400 µm	20170
@NP	-LRB- G -RRB- Arborising fine nerve sprouts -LRB- arrow -RRB-	20178
@NP	-LRB- G -RRB- Arborising fine nerve sprouts	20178
@NP	-LRB- G -RRB-	20178
@NP	Arborising fine nerve sprouts	20182
@NP	arrow	20213
@NP	aggregates of fluorescent cells , presumably macrophages	20261
@NP	aggregates	20261
@NP	fluorescent cells , presumably macrophages	20275
@NP	fluorescent cells	20275
@NP	macrophages	20305
@NP	Scale	20318
@NP	150 µm	20330
@NP	Section	20342
@NP	a region of spinal cord caudal to the lesion and which received	20355
@NP	a region of spinal cord caudal to the lesion	20355
@NP	a region	20355
@NP	spinal cord caudal to the lesion	20367
@NP	spinal cord caudal	20367
@NP	the lesion	20389
@NP	ECs	20432
@NP	A collateral branch -LRB- arrows -RRB-	20437
@NP	A collateral branch	20437
@NP	arrows	20458
@NP	the ventral corticospinal tract in the ventral funiculus	20471
@NP	the ventral corticospinal tract	20471
@NP	the ventral funiculus	20506
@NP	across the grey matter and then projects	20536
@NP	the grey matter	20543
@NP	the region where the original dorsal corticospinal tract was located	20589
@NP	the region	20589
@NP	the original dorsal corticospinal tract	20606
@NP	Scale	20659
@NP	600 µm	20671
@NP	-LRB- I -RRB- Similar section	20679
@NP	I	20680
@NP	caudal to the lesion from a different rat which received encapsulated ECs	20699
@NP	caudal	20699
@NP	the lesion from a different rat which received encapsulated ECs	20709
@NP	the lesion	20709
@NP	a different rat which received encapsulated ECs	20725
@NP	a different rat	20725
@NP	ECs	20769
@NP	Fibres of the vCST -LRB- arrowheads -RRB-	20774
@NP	Fibres	20774
@NP	the vCST -LRB- arrowheads -RRB-	20784
@NP	the vCST	20784
@NP	arrowheads	20794
@NP	the ventral funiculus	20830
@NP	A caudally projecting fibre -LRB- arrows -RRB- in the dorsal funiculus	20853
@NP	fibre -LRB- arrows -RRB- in the dorsal	20875
@NP	fibre -LRB- arrows -RRB-	20875
@NP	fibre	20875
@NP	arrows	20882
@NP	the dorsal	20893
@NP	the fibre network present in the grey matter	20930
@NP	the fibre network	20930
@NP	the grey matter	20959
@NP	Scale	20976
@NP	800 µm	20988
@NP	Fig. 5 .	20997
@NP	Fig.	20997
@NP	5	21002
@NP	-LRB- A -RRB- Olfactory ensheathing	21005
@NP	A	21006
@NP	cells labeled with Hoescht blue before implantation	21031
@NP	cells	21031
@NP	Hoescht blue	21050
@NP	implantation	21070
@NP	Scale	21084
@NP	40 µm	21096
@NP	-LRB- B -RRB- Injection site -LRB- asterisk -RRB- in spinal cord	21103
@NP	-LRB- B -RRB- Injection site	21103
@NP	-LRB- B -RRB-	21103
@NP	Injection site	21107
@NP	asterisk	21123
@NP	spinal cord	21136
@NP	aggregates of ECs prelabeled with Hoescht blue	21162
@NP	aggregates	21162
@NP	ECs prelabeled with Hoescht blue	21176
@NP	ECs	21176
@NP	Hoescht blue	21196
@NP	Ensheathing cells	21210
@NP	their blue fluorescence -LRB- arrow , inset -RRB-	21252
@NP	their blue fluorescence	21252
@NP	arrow , inset	21277
@NP	arrow	21277
@NP	the autofluorescence	21297
@NP	macrophages -LRB- arrowhead , inset -RRB- is yellowish crystalloid in appearance	21321
@NP	macrophages -LRB- arrowhead , inset -RRB-	21321
@NP	macrophages	21321
@NP	arrowhead , inset	21334
@NP	arrowhead	21334
@NP	yellowish crystalloid in appearance	21355
@NP	yellowish crystalloid	21355
@NP	appearance	21380
@NP	this specimen	21395
@NP	no fibres	21410
@NP	the injection site or ECs	21437
@NP	the injection site	21437
@NP	ECs	21459
@NP	Scale bar = 250	21464
@NP	Scale bar	21464
@NP	250	21476
@NP	Scale	21484
@NP	inset = 125 µm	21497
@NP	inset	21497
@NP	125 µm	21505
@NP	-LRB- C -RRB- Only a few ECs -LRB- arrow -RRB-	21513
@NP	-LRB- C -RRB- Only a few ECs	21513
@NP	-LRB- C -RRB-	21513
@NP	Only a few ECs	21517
@NP	arrow	21533
@NP	this injection site -LRB- asterisk -RRB-	21557
@NP	this injection site	21557
@NP	asterisk	21578
@NP	Scale	21589
@NP	180 µm	21601
@NP	Fig. 6 .	21610
@NP	Fig.	21610
@NP	6	21615
@NP	-LRB- A -RRB- Graphical presentation of the ratio of axonal collateral branches	21618
@NP	-LRB- A -RRB- Graphical presentation	21618
@NP	A	21619
@NP	the ratio of axonal collateral branches	21648
@NP	the ratio	21648
@NP	axonal collateral branches	21661
@NP	the number of ventral corticospinal fibres	21700
@NP	the number	21700
@NP	ventral corticospinal fibres	21714
@NP	The group which received EC injections	21744
@NP	The group	21744
@NP	EC injections	21769
@NP	significantly more collateral branches	21787
@NP	the group	21831
@NP	culture medium -LRB- CM -RRB- injections	21861
@NP	CM	21877
@NP	P	21894
@NP	0.003	21898
@NP	these two groups	21909
@NP	a capsule containing CM	21927
@NP	a capsule	21927
@NP	CM	21948
@NP	the spinal cord	21972
@NP	comparison	21992
@NP	the group that received encapsulated ECs	22004
@NP	the group	22004
@NP	ECs	22041
@NP	a similar trend	22052
@NP	increased collateral	22071
@NP	the difference with the corresponding control	22111
@NP	the difference	22111
@NP	the corresponding control	22131
@NP	P = 0.07	22193
@NP	P	22193
@NP	= 0.07	22195
@NP	There	22204
@NP	no statistical difference	22214
@NP	the group	22248
@NP	EC injections	22272
@NP	the one that received encapsulated ECs	22291
@NP	the one	22291
@NP	ECs	22326
@NP	P	22332
@NP	1.00	22336
@NP	-LRB- B -RRB- Graphical presentation	22343
@NP	B	22344
@NP	the ratio of fibre terminations in the grey matter	22373
@NP	the ratio	22373
@NP	fibre terminations in the grey matter	22386
@NP	fibre terminations	22386
@NP	the grey matter	22408
@NP	the number of ventral corticospinal fibres	22436
@NP	the number	22436
@NP	ventral corticospinal fibres	22450
@NP	The two groups which received either EC injections or encapsulated ECs	22480
@NP	The two groups	22480
@NP	EC injections	22517
@NP	ECs	22547
@NP	a trend	22558
@NP	increased ratio of terminating fibres in the grey matter caudal to the lesion	22569
@NP	increased ratio	22569
@NP	fibres in the grey matter caudal	22600
@NP	fibres	22600
@NP	the grey matter caudal	22610
@NP	the lesion	22636
@NP	Data	22648
@NP	mean ± SEM	22670
@NP	Histology and axonal labeling Previous studies	22683
@NP	Histology	22683
@NP	axonal labeling Previous studies	22697
@NP	corticospinal neurons	22746
@NP	the motor cortex	22792
@NP	some other cortical areas	22821
@NP	the supplementary motor area	22857
@NP	prefrontal cortex and somatosensory cortex	22887
@NP	Li	22931
@NP	et al. , 1990 ; Miller , 1987	22934
@NP	et al.	22934
@NP	1990 ; Miller	22942
@NP	1990	22942
@NP	Miller	22948
@NP	1987	22956
@NP	the basis these findings and several experimental trials	22966
@NP	the basis these findings	22966
@NP	the basis	22966
@NP	these findings	22976
@NP	several experimental trials	22995
@NP	we	23024
@NP	bilateral injection	23043
@NP	Fluororuby into the hindlimb motor and somatosensory cortex	23066
@NP	Fluororuby	23066
@NP	the hindlimb motor and somatosensory cortex	23082
@NP	intense labeling of the corticospinal tracts -LRB- Fig. 1B -RRB-	23148
@NP	intense labeling	23148
@NP	the corticospinal tracts -LRB- Fig. 1B -RRB-	23168
@NP	the corticospinal tracts	23168
@NP	Fig. 1B	23194
@NP	the uninjured rat	23207
@NP	the number of fibres in the bilateral dCST	23226
@NP	the number	23226
@NP	fibres in the bilateral dCST	23240
@NP	fibres	23240
@NP	the bilateral dCST	23250
@NP	339 ± 18	23278
@NP	348 ± 11 and 284 ± 28 at the cervical , upper and middle thoracic levels	23288
@NP	348 ±	23288
@NP	11 and 284 ± 28 at the cervical , upper and middle thoracic levels	23294
@NP	11 and 284 ± 28	23294
@NP	the cervical , upper and middle thoracic levels	23313
@NP	Fig. 2A	23375
@NP	The fibres	23385
@NP	compact arrangement	23412
@NP	two well-defined tracts	23435
@NP	The smaller component of vCST	23460
@NP	The smaller component	23460
@NP	vCST	23485
@NP	55 ± 4 fibres bilaterally at the mid-thoracic level and fibres	23499
@NP	55 ± 4 fibres	23499
@NP	the mid-thoracic level and fibres	23528
@NP	the mid-thoracic level	23528
@NP	fibres	23555
@NP	a wide area of the ventral funiculus	23594
@NP	a wide area	23594
@NP	the ventral funiculus	23609
@NP	previous studies -LRB- Liang et al. , 1991 ; Weidner et al. , 2001 -RRB-	23647
@NP	previous studies	23647
@NP	Liang	23665
@NP	et al. , 1991 ; Weidner et al. , 2001	23671
@NP	et al.	23671
@NP	1991 ; Weidner et al.	23679
@NP	1991	23679
@NP	Weidner et al.	23685
@NP	Weidner	23685
@NP	et al.	23693
@NP	2001	23701
@NP	we	23708
@NP	a few corticospinal fibres	23735
@NP	fewer than six on each side	23781
@NP	fewer than six	23781
@NP	each side	23799
@NP	the lateral funiculi , just ventral to the dorsal horns	23827
@NP	the lateral funiculi	23827
@NP	ventral to the dorsal horns	23854
@NP	the dorsal	23865
@NP	Axonal counts	23883
@NP	rostral	23897
@NP	the injury site	23908
@NP	The number of Fluororuby-labeled dCST axons	23924
@NP	The number	23924
@NP	Fluororuby-labeled dCST axons	23938
@NP	all groups at the cervical , upper and mid-thoracic levels	23983
@NP	all groups	23983
@NP	the cervical , upper and mid-thoracic levels	23997
@NP	Fig. 2A	24042
@NP	the cervical , upper and mid-thoracic level	24055
@NP	there	24099
@NP	no statistically significant difference in the number of dCST fibres	24109
@NP	no statistically significant difference	24109
@NP	the number of dCST fibres	24152
@NP	the number	24152
@NP	dCST fibres	24166
@NP	all treatment groups	24181
@NP	a higher number	24212
@NP	fibres in the groups that received ECs	24231
@NP	fibres	24231
@NP	the groups that received ECs	24241
@NP	the groups	24241
@NP	ECs	24266
@NP	the mid-thoracic level	24313
@NP	The control group	24337
@NP	CM-containing capsules	24369
@NP	CM injections	24406
@NP	the least number of fibres	24424
@NP	the least number	24424
@NP	fibres	24444
@NP	86 F 20 fibres at the mid-thoracic level	24456
@NP	86 F 20 fibres	24456
@NP	the mid-thoracic level	24474
@NP	This value	24498
@NP	27 F	24523
@NP	the number of fibres present at the cervical level -LRB- Fig. 2B -RRB-	24534
@NP	the number	24534
@NP	fibres present at the cervical level -LRB- Fig. 2B -RRB-	24548
@NP	fibres present at the cervical level	24548
@NP	fibres	24548
@NP	the cervical level	24566
@NP	Fig. 2B	24586
@NP	the other control group which received only a CM-containing capsule	24608
@NP	the other control group	24608
@NP	only a CM-containing capsule	24647
@NP	this group	24677
@NP	additional acute injury	24698
@NP	multiple CM injections , hence the comparatively fewer fibres that were labeled	24727
@NP	multiple CM injections	24727
@NP	the comparatively fewer fibres that were labeled	24757
@NP	the comparatively fewer fibres	24757
@NP	The persistence	24807
@NP	Fluororuby-labeled fibres	24826
@NP	5 weeks post-axotomy even in the absence of any cellular transplants	24855
@NP	5 weeks post-axotomy	24855
@NP	the absence of any cellular transplants	24884
@NP	the absence	24884
@NP	any cellular transplants	24899
@NP	a considerable proportion of dCST neurons	24938
@NP	a considerable proportion	24938
@NP	dCST neurons	24967
@NP	This	24995
@NP	it	25035
@NP	neurons	25062
@NP	chromatolysis and eventual cell death	25078
@NP	traumatic injury -LRB- e.g. , Schwab and Bartholdi , 1996 -RRB-	25126
@NP	traumatic injury	25126
@NP	e.g. , Schwab and Bartholdi , 1996	25144
@NP	e.g.	25144
@NP	Schwab and Bartholdi	25150
@NP	1996	25172
@NP	Corticospinal tract fibres	25179
@NP	the lesion site Dissection of the spinal cord at 5 weeks post-surgery	25211
@NP	the lesion site Dissection	25211
@NP	the spinal cord at 5 weeks post-surgery	25241
@NP	the spinal cord	25241
@NP	5 weeks	25260
@NP	this time	25300
@NP	a layer of fibrous connective tissue	25311
@NP	a layer	25311
@NP	fibrous connective tissue	25322
@NP	the capsule	25363
@NP	a slight protrusion on the dorsal surface -LRB- Chuah and West , 2002 -RRB-	25386
@NP	a slight protrusion	25386
@NP	the dorsal surface -LRB- Chuah and West , 2002 -RRB-	25409
@NP	the dorsal surface	25409
@NP	Chuah and West	25429
@NP	2002	25445
@NP	Longitudinal sections	25452
@NP	the capsule	25488
@NP	the spinal cord	25525
@NP	the recovery period -LRB- Fig. 3 -RRB-	25548
@NP	the recovery period	25548
@NP	Fig. 3	25569
@NP	some animals	25584
@NP	some compression of the vCST	25608
@NP	some compression	25608
@NP	the vCST	25628
@NP	The cut edge of the dCST	25638
@NP	The cut edge	25638
@NP	the dCST	25654
@NP	a bright red fluorescent bundle	25678
@NP	the axotomised edge	25715
@NP	the rostral tip of the capsule -LRB- Figs. 3 and 4A -RRB-	25755
@NP	the rostral tip	25755
@NP	the capsule -LRB- Figs. 3 and 4A -RRB-	25774
@NP	the capsule	25774
@NP	Figs. 3 and 4A	25787
@NP	Figs. 3	25787
@NP	4A	25799
@NP	both control and EC-treated rats	25807
@NP	both control	25807
@NP	EC-treated rats	25824
@NP	small numbers of nerve sprouts	25841
@NP	small numbers	25841
@NP	nerve sprouts	25858
@NP	the cut stump and sides of the dCST -LRB- Fig. 4B -RRB-	25901
@NP	the cut stump	25901
@NP	sides of the dCST -LRB- Fig. 4B -RRB-	25919
@NP	sides	25919
@NP	the dCST -LRB- Fig. 4B -RRB-	25928
@NP	the dCST	25928
@NP	Fig. 4B	25938
@NP	Small numbers of regenerating fibres	25948
@NP	Small numbers	25948
@NP	regenerating fibres	25965
@NP	10	25992
@NP	EC-treated rats	26012
@NP	the EC-encapsulated rats	26032
@NP	the regenerating fibres	26058
@NP	close association with the capsule , along its sides and caudally	26099
@NP	close association with the capsule	26099
@NP	close association	26099
@NP	the capsule	26122
@NP	its sides	26141
@NP	Figs. 4C , D and E	26173
@NP	Figs. 4C	26173
@NP	D and E	26183
@NP	These regenerating fibres	26193
@NP	axonal varicosities	26241
@NP	they	26265
@NP	a parallel direction , typical of dCST fibres	26309
@NP	a parallel direction	26309
@NP	typical of dCST fibres	26331
@NP	typical	26331
@NP	dCST fibres	26342
@NP	rats that received encapsulated ECs	26358
@NP	rats	26358
@NP	ECs	26390
@NP	some nerve fibres	26395
@NP	the caudal edge	26456
@NP	the capsule	26475
@NP	Fig. 4E	26488
@NP	a location	26498
@NP	directional growth	26513
@NP	the normal trajectory of the dCST	26561
@NP	the normal trajectory	26561
@NP	the dCST	26586
@NP	contrast	26599
@NP	rats that had ECs injected directly into the spinal cord	26612
@NP	rats	26612
@NP	ECs injected directly into the spinal cord	26626
@NP	ECs	26626
@NP	the spinal cord	26653
@NP	fine nerve fibres	26670
@NP	the caudal tip of the CM-containing capsule -LRB- Fig. 4F -RRB-	26717
@NP	the caudal tip	26717
@NP	the CM-containing capsule -LRB- Fig. 4F -RRB-	26735
@NP	the CM-containing capsule	26735
@NP	Fig. 4F	26762
@NP	The longest of these caudally projecting fibres	26772
@NP	The longest	26772
@NP	these caudally projecting fibres	26787
@NP	these	26787
@NP	fibres	26813
@NP	10 mm distal to the caudal edge of the capsule	26839
@NP	10 mm	26839
@NP	the caudal edge of the capsule	26854
@NP	the caudal edge	26854
@NP	the capsule	26873
@NP	summary	26889
@NP	the observations	26898
@NP	there	26929
@NP	a few regenerating fibres	26940
@NP	the sectioned dCST	26971
@NP	rats which had received ECs -LRB- encapsulated or injected -RRB-	26993
@NP	rats	26993
@NP	ECs -LRB- encapsulated or injected -RRB-	27017
@NP	ECs	27017
@NP	regeneration	27058
@NP	large areas of necrosis , macrophages and tissue scarring	27096
@NP	large areas	27096
@NP	necrosis , macrophages and tissue scarring	27111
@NP	both control and EC-treated rats	27156
@NP	control	27161
@NP	EC-treated rats	27173
@NP	It	27190
@NP	some of the regenerating sprouts	27211
@NP	some	27211
@NP	the regenerating sprouts	27219
@NP	areas of brightly fluorescent cells	27274
@NP	areas	27274
@NP	brightly fluorescent cells	27283
@NP	macrophages -LRB- Fig. 4G -RRB-	27322
@NP	macrophages	27322
@NP	Fig. 4G	27335
@NP	The small number of regenerating fibres	27345
@NP	The small number	27345
@NP	regenerating fibres	27365
@NP	the finding	27404
@NP	there	27421
@NP	statistically significant differences	27436
@NP	the number of dCST fibres rostral to the lesion	27477
@NP	the number	27477
@NP	dCST fibres rostral to the lesion	27491
@NP	dCST fibres rostral	27491
@NP	the lesion	27514
@NP	contrast to the dense , compact arrangement of fibres in the dCST	27529
@NP	contrast	27529
@NP	the dense , compact arrangement of fibres in the dCST	27541
@NP	the dense , compact arrangement	27541
@NP	fibres in the dCST	27575
@NP	fibres	27575
@NP	the dCST	27585
@NP	the brightly labeled vCST	27595
@NP	fibres	27636
@NP	a wide area in the ventral half of the spinal cord	27669
@NP	a wide area	27669
@NP	the ventral half of the spinal cord	27684
@NP	the ventral half	27684
@NP	the spinal cord	27704
@NP	a few animals that received encapsulated or injected ECs	27724
@NP	a few animals	27724
@NP	ECs	27777
@NP	branches from the vCST caudal to the lesion	27782
@NP	branches	27782
@NP	the vCST caudal to the lesion	27796
@NP	the vCST caudal	27796
@NP	the lesion	27815
@NP	the dorsal columns	27838
@NP	the space originally occupied	27878
@NP	the space	27878
@NP	the dCST -LRB- Fig. 4H -RRB-	27911
@NP	the dCST	27911
@NP	Fig. 4H	27921
@NP	These fibres	27931
@NP	new collateral sprouts	27949
@NP	they	27980
@NP	any axonal branches or terminations	28001
@NP	they	28040
@NP	the grey matter	28061
@NP	addition	28081
@NP	some EC-treated -LRB- injected or encapsulated -RRB- rats	28094
@NP	fibres in the dorsal	28163
@NP	fibres	28163
@NP	the dorsal	28173
@NP	columns , caudal to the lesion ,	28184
@NP	columns	28184
@NP	the lesion	28203
@NP	a network in the grey matter -LRB- Fig. 4I -RRB-	28247
@NP	a network	28247
@NP	the grey matter -LRB- Fig. 4I -RRB-	28260
@NP	the grey matter	28260
@NP	Fig. 4I	28277
@NP	This unusual axonal route	28287
@NP	Figs. 4H	28329
@NP	I	28342
@NP	animals from both control groups	28364
@NP	animals	28364
@NP	both control groups	28377
@NP	ECs injected directly into the spinal cord	28407
@NP	ECs	28407
@NP	the spinal cord	28434
@NP	Hoescht blue -LRB- Fig. 5A -RRB-	28485
@NP	Hoescht blue	28485
@NP	Fig. 5A	28499
@NP	there	28509
@NP	difficulty in localising the cells 5 weeks posttransplantation	28519
@NP	difficulty	28519
@NP	the cells 5 weeks posttransplantation	28544
@NP	cells	28548
@NP	5 weeks	28554
@NP	some animals	28586
@NP	ECs	28600
@NP	the injection site -LRB- Fig. 5B -RRB-	28618
@NP	the injection site	28618
@NP	Fig. 5B	28638
@NP	others	28657
@NP	very few ECs	28665
@NP	Fig. 5C	28692
@NP	Viable ECs	28702
@NP	the yellowish crystalloid autofluorescence	28741
@NP	macrophages -LRB- Bunn et al. , 2002 ; Fig. 6 in Takami et al. , 2002 -RRB-	28787
@NP	macrophages	28787
@NP	Bunn	28800
@NP	et al. , 2002 ; Fig. 6 in Takami et al. , 2002	28805
@NP	et al.	28805
@NP	2002 ; Fig. 6 in Takami et al.	28813
@NP	2002	28813
@NP	Fig. 6 in Takami et al.	28819
@NP	Fig. 6 in Takami	28819
@NP	Fig. 6	28819
@NP	Takami	28829
@NP	et al.	28836
@NP	2002	28844
@NP	their blue fluorescence under UV stimulation -LRB- Fig. 5B , inset	28853
@NP	their blue fluorescence under UV stimulation -LRB- Fig. 5B ,	28853
@NP	their blue fluorescence under UV stimulation	28853
@NP	their blue fluorescence	28853
@NP	UV stimulation	28883
@NP	Fig. 5B	28899
@NP	small areas where the two types of fluorescence overlapped	28919
@NP	small areas	28919
@NP	the two types of fluorescence	28937
@NP	the two types	28937
@NP	fluorescence	28954
@NP	it	28979
@NP	the fluorescence	28999
@NP	a consequence of macrophages having phagocytosed dead ECs	29025
@NP	a consequence	29025
@NP	macrophages	29042
@NP	dead ECs	29074
@NP	Axonal	29084
@NP	the ventral corticospinal tract	29106
@NP	addition	29141
@NP	the number of labeled vCST fibres	29153
@NP	the number	29153
@NP	labeled vCST fibres	29167
@NP	axonal fibres observed to be clearly branching directly from the vCST	29188
@NP	axonal fibres	29188
@NP	the vCST	29249
@NP	Fig. 4H	29271
@NP	Initial overview	29299
@NP	there	29328
@NP	variability in the proportion of labeled fibres in the vCST	29338
@NP	variability	29338
@NP	the proportion of labeled fibres in the vCST	29353
@NP	the proportion	29353
@NP	labeled fibres in the vCST	29371
@NP	labeled fibres	29371
@NP	the vCST	29389
@NP	This	29399
@NP	part to the fact	29414
@NP	part	29414
@NP	the fact	29422
@NP	the total number of fibres in this tract	29436
@NP	the total number	29436
@NP	fibres in this tract	29456
@NP	fibres	29456
@NP	this tract	29466
@NP	that of the dCST , about 19 % and probably	29503
@NP	that of the dCST	29503
@NP	that	29503
@NP	the dCST	29511
@NP	19 %	29527
@NP	the motor neurons	29557
@NP	a wider cortical region	29594
@NP	the data	29632
@NP	the number of axonal branches and terminations	29642
@NP	the number	29642
@NP	axonal branches and terminations	29656
@NP	a ratio of the number of labeled vCST fibres -LRB- Figs. 6A and B -RRB-	29706
@NP	a ratio	29706
@NP	the number of labeled vCST fibres -LRB- Figs. 6A and B -RRB-	29717
@NP	the number	29717
@NP	labeled vCST fibres -LRB- Figs. 6A and B -RRB-	29731
@NP	labeled vCST fibres	29731
@NP	Figs. 6A and B	29752
@NP	Figs. 6A	29752
@NP	B	29765
@NP	ANOVA analysis of the data	29769
@NP	ANOVA analysis	29769
@NP	the data	29787
@NP	there	29808
@NP	a statistically significant difference	29818
@NP	treatment groups -LRB- P = 0.01 -RRB-	29863
@NP	treatment groups	29863
@NP	P	29882
@NP	0.01	29886
@NP	The two control groups	29893
@NP	lesion	29917
@NP	transplantation of CM-filled capsule	29929
@NP	transplantation	29929
@NP	CM-filled capsule	29948
@NP	lesion with transplantation of CM-filled capsule	29967
@NP	lesion	29967
@NP	transplantation of CM-filled capsule	29979
@NP	transplantation	29979
@NP	CM-filled capsule	29998
@NP	injections of CM	30021
@NP	injections	30021
@NP	CM	30035
@NP	markedly lower ratios of branches	30043
@NP	markedly lower ratios	30043
@NP	branches	30068
@NP	fibres	30080
@NP	the unlesioned group	30101
@NP	This	30123
@NP	the fact	30151
@NP	the ventrally displaced capsule	30165
@NP	some of the branches of the vCST	30205
@NP	some	30205
@NP	the branches of the vCST	30213
@NP	the branches	30213
@NP	the vCST	30229
@NP	the control group that received injections of CM	30245
@NP	the control group	30245
@NP	injections of CM	30277
@NP	injections	30277
@NP	CM	30291
@NP	additional acute injury	30304
@NP	Pair-wise comparison	30329
@NP	spinal cords that had ECs injected into the vicinity of the lesion	30362
@NP	spinal cords	30362
@NP	ECs injected into the vicinity of the lesion	30384
@NP	ECs	30384
@NP	the vicinity of the lesion	30402
@NP	the vicinity	30402
@NP	the lesion	30418
@NP	significantly more branches	30433
@NP	intact vCST fibres	30466
@NP	the corresponding control animals -LRB- P = 0.003 -RRB-	30499
@NP	the corresponding control animals	30499
@NP	P	30535
@NP	0.003	30539
@NP	there	30562
@NP	a trend	30572
@NP	the spinal cords	30584
@NP	ECs	30623
@NP	more axonal branches	30635
@NP	those which received CM containing capsules	30661
@NP	those	30661
@NP	CM	30682
@NP	capsules	30696
@NP	P	30706
@NP	0.07	30710
@NP	No significant difference in axonal branching	30717
@NP	No significant difference	30717
@NP	axonal branching	30746
@NP	axonal	30746
@NP	a comparison	30779
@NP	the EC-injected and EC-encapsulated groups -LRB- P = 1.00 -RRB-	30800
@NP	the EC-injected and EC-encapsulated groups	30800
@NP	P	30845
@NP	1.00	30849
@NP	The ratio of fibre terminations in the grey matter to vCST fibres	30856
@NP	The ratio	30856
@NP	fibre terminations in the grey matter to vCST fibres	30869
@NP	fibre terminations	30869
@NP	the grey matter to vCST fibres	30891
@NP	the grey matter	30891
@NP	vCST fibres	30910
@NP	treatment groups -LRB- Fig. 6B -RRB-	30943
@NP	treatment groups	30943
@NP	Fig. 6B	30961
@NP	it	30980
@NP	there	31014
@NP	more fibre terminations in the two groups that received ECs	31025
@NP	more fibre terminations	31025
@NP	the two groups	31052
@NP	ECs	31081
@NP	the group that had ECs injected into the vicinity of the lesion	31101
@NP	the group	31101
@NP	ECs injected into the vicinity of the lesion	31120
@NP	ECs	31120
@NP	the vicinity of the lesion	31138
@NP	the vicinity	31138
@NP	the lesion	31154
@NP	a mean value of 9.2 ± 2.7 terminations per fibre	31169
@NP	a mean value	31169
@NP	9.2 ± 2.7 terminations per fibre	31185
@NP	9.2 ± 2.7 terminations	31185
@NP	fibre	31212
@NP	its control which had only 3.1 ± 0.7 -LRB- P = 0.075 -RRB-	31232
@NP	its control	31232
@NP	only 3.1 ± 0.7	31254
@NP	P	31270
@NP	0.075	31274
@NP	Discussion We have compared the effect of	31283
@NP	Discussion	31283
@NP	We	31294
@NP	the effect of	31311
@NP	the effect	31311
@NP	injected ECs on collateral axonal sprouting	31345
@NP	injected ECs	31345
@NP	collateral axonal sprouting	31361
@NP	collateral axonal	31361
@NP	regeneration	31393
@NP	the injured spinal cord	31409
@NP	We	31434
@NP	the first time	31452
@NP	collateral axonal branching from the intact vCST	31472
@NP	collateral axonal	31472
@NP	the intact vCST	31505
@NP	the presence of ECs	31551
@NP	the presence	31551
@NP	ECs	31567
@NP	A small number of regenerating fibres	31572
@NP	A small number	31572
@NP	regenerating fibres	31590
@NP	the two groups	31626
@NP	rats	31644
@NP	ECs -LRB- encapsulated and injected -RRB-	31664
@NP	ECs	31664
@NP	results that have been reported previously by other research groups	31713
@NP	results	31713
@NP	other research groups	31759
@NP	Ramon-Cueto	31782
@NP	et al. , 2000 ; Takami et al. , 2002	31794
@NP	et al.	31794
@NP	2000 ; Takami et al.	31802
@NP	2000	31802
@NP	Takami et al.	31808
@NP	Takami	31808
@NP	et al.	31815
@NP	2002	31823
@NP	Response of vCST to injury in the dorsal columns	31830
@NP	Response	31830
@NP	vCST to injury in the dorsal columns	31842
@NP	vCST	31842
@NP	injury in the dorsal columns	31850
@NP	injury	31850
@NP	the dorsal columns	31860
@NP	this study , ECs transplanted into the spinal cord following injury to dCST	31882
@NP	this study	31882
@NP	ECs transplanted into the spinal cord following injury to dCST	31894
@NP	ECs	31894
@NP	the spinal cord following injury to dCST	31916
@NP	the spinal cord	31916
@NP	injury to dCST	31942
@NP	injury	31942
@NP	dCST	31952
@NP	increased collateral branches from the vCST	31969
@NP	increased collateral branches	31969
@NP	the vCST	32004
@NP	These new branches	32014
@NP	the grey matter	32054
@NP	the original path of the dCST	32110
@NP	the original path	32110
@NP	the dCST	32131
@NP	The response of vCST to injury in the dCST	32141
@NP	The response	32141
@NP	vCST to injury in the dCST	32157
@NP	vCST	32157
@NP	injury in the dCST	32165
@NP	injury	32165
@NP	the dCST	32175
@NP	ECtransplantation studies	32217
@NP	this observation of collateral sprouting	32248
@NP	this observation	32248
@NP	collateral sprouting	32268
@NP	collateral	32268
@NP	the accurate interpretation of results	32318
@NP	the accurate interpretation	32318
@NP	results	32349
@NP	nerve fibres	32365
@NP	their origin	32392
@NP	their mere presence in the dorsal column caudal to a dCST lesion	32406
@NP	their mere presence	32406
@NP	the dorsal column caudal to a dCST lesion	32429
@NP	the dorsal column caudal	32429
@NP	a dCST lesion	32457
@NP	regenerating fibres	32503
@NP	It	32524
@NP	previous studies	32544
@NP	the presence of regenerating dCST fibres following EC transplantation	32576
@NP	the presence	32576
@NP	dCST fibres following EC transplantation	32605
@NP	dCST fibres	32605
@NP	EC transplantation	32627
@NP	axons	32666
@NP	vCST in their observations	32677
@NP	vCST	32677
@NP	their observations	32685
@NP	Li et al. , 1998 ; Nash et al. , 2002 ; Takami et al. , 2002	32705
@NP	Li	32705
@NP	et al. , 1998 ; Nash et al. , 2002 ; Takami et al. , 2002	32708
@NP	et al. , 1998	32708
@NP	et al.	32708
@NP	1998	32716
@NP	Nash et al. , 2002	32722
@NP	Nash	32722
@NP	et al. , 2002	32727
@NP	et al.	32727
@NP	2002	32735
@NP	Takami et al. , 2002	32741
@NP	Takami	32741
@NP	et al. , 2002	32748
@NP	et al.	32748
@NP	2002	32756
@NP	Li et al. -LRB- 1998 -RRB-	32763
@NP	Li et al.	32763
@NP	Li	32763
@NP	et al.	32766
@NP	1998	32774
@NP	CST axons	32788
@NP	biotin dextran	32811
@NP	the medullary pyramid or the entire contralateral sensorimotor cortex	32838
@NP	the medullary pyramid	32838
@NP	the entire contralateral sensorimotor cortex	32863
@NP	Such an extensive injection	32909
@NP	the vCST	32968
@NP	a recent study in which the thoracic spinal cord was contused	32981
@NP	a recent study	32981
@NP	the thoracic spinal cord	33005
@NP	a quantitative analysis	33044
@NP	the number	33080
@NP	fibres	33094
@NP	the dorsal column rostral	33104
@NP	the lesion	33142
@NP	Takami	33154
@NP	et al. , 2002	33161
@NP	et al.	33161
@NP	2002	33169
@NP	the authors	33185
@NP	the presence of the fibres near the lesion	33211
@NP	the presence	33211
@NP	the fibres near the lesion	33227
@NP	the fibres	33227
@NP	the lesion	33243
@NP	regeneration	33271
@NP	they	33285
@NP	some	33309
@NP	the spared vCST	33340
@NP	a total transection of the spinal cord	33364
@NP	a total transection	33364
@NP	the spinal cord	33387
@NP	the neuroanatomical contribution of collateral sprouting to fibres	33417
@NP	the neuroanatomical contribution	33417
@NP	collateral sprouting to fibres	33453
@NP	collateral	33453
@NP	fibres	33477
@NP	the lesion can not be entirely discounted	33494
@NP	the lesion	33494
@NP	the contribution	33547
@NP	collateral sprouting from descending motor tracts to functional recovery	33567
@NP	collateral	33567
@NP	motor tracts	33604
@NP	functional recovery	33620
@NP	Murray and Goldberger	33670
@NP	1974	33693
@NP	An early report	33700
@NP	mid-brain	33753
@NP	tracts	33771
@NP	thoracic spinal cord sectioning -LRB- Prendergast and Misantone , 1980 -RRB-	33788
@NP	thoracic spinal cord sectioning	33788
@NP	Prendergast and Misantone , 1980	33821
@NP	Prendergast and Misantone	33821
@NP	1980	33848
@NP	the sparing of a few fibres in the ventral funiculus of the rat spinal cord	33870
@NP	the sparing	33870
@NP	a few fibres in the ventral funiculus of the rat spinal cord	33885
@NP	a few fibres	33885
@NP	the ventral funiculus of the rat spinal cord	33901
@NP	the ventral funiculus	33901
@NP	the rat spinal cord	33926
@NP	abilities	33995
@NP	locomotion -LRB- Schucht et al. , 2002 -RRB-	34008
@NP	locomotion	34008
@NP	Schucht	34020
@NP	et al. , 2002	34028
@NP	et al.	34028
@NP	2002	34036
@NP	A study on adult rats	34043
@NP	A study	34043
@NP	adult rats	34054
@NP	spontaneous sprouting from the vCST following lesion of the dCST	34079
@NP	spontaneous	34079
@NP	the vCST following lesion of the dCST	34106
@NP	the vCST	34106
@NP	lesion of the dCST	34125
@NP	lesion	34125
@NP	the dCST	34135
@NP	the rats ' ability to retrieve food pellets	34160
@NP	the rats '	34160
@NP	food pellets	34190
@NP	the vCST	34207
@NP	functional recovery	34242
@NP	Weidner et al. , 2001	34277
@NP	Weidner	34277
@NP	et al.	34285
@NP	2001	34293
@NP	Influence of ECs on the response of the vCST	34300
@NP	Influence	34300
@NP	ECs on the response of the vCST	34313
@NP	ECs	34313
@NP	the response of the vCST	34320
@NP	the response	34320
@NP	the vCST	34336
@NP	a statistically significant increase in collateral sprouting	34354
@NP	a statistically significant increase	34354
@NP	collateral sprouting	34394
@NP	collateral	34394
@NP	rats	34436
@NP	ECs	34450
@NP	the injury site , those that received encapsulated ECs	34477
@NP	the injury site	34477
@NP	those that received encapsulated ECs	34494
@NP	those	34494
@NP	ECs	34527
@NP	a trend for increased branching -LRB- P = 0.07 -RRB-	34544
@NP	a trend	34544
@NP	increased branching -LRB- P = 0.07 -RRB-	34556
@NP	increased branching	34556
@NP	P	34577
@NP	0.07	34581
@NP	the group that received EC injections was compared with the one that received	34593
@NP	the group	34593
@NP	EC injections	34617
@NP	the one that received	34649
@NP	the one	34649
@NP	ECs	34684
@NP	there	34689
@NP	no clear statistically significant difference between them -LRB- P = 1.00 -RRB-	34699
@NP	no clear statistically significant difference	34699
@NP	them	34753
@NP	P	34759
@NP	1.00	34763
@NP	The promotion of collateral sprouting by diffusible growth factors	34770
@NP	The promotion	34770
@NP	collateral sprouting by diffusible growth factors	34787
@NP	collateral	34787
@NP	diffusible growth factors	34811
@NP	evidence	34853
@NP	numerous studies	34867
@NP	different types	34887
@NP	neurons	34906
@NP	Cohen-Cory and Fraser	34915
@NP	Cohen-Cory	34915
@NP	Fraser	34930
@NP	1995 ; Gallo and Letourneau , 1998 ; He et al. , 1992 ; Schnell et al. , 1994	34938
@NP	1995	34938
@NP	Gallo and Letourneau , 1998 ; He et al. , 1992 ; Schnell et al. , 1994	34944
@NP	Gallo and Letourneau , 1998	34944
@NP	Gallo and Letourneau	34944
@NP	1998	34966
@NP	He et al. , 1992	34972
@NP	He	34972
@NP	et al. , 1992	34975
@NP	et al.	34975
@NP	1992	34983
@NP	Schnell et al. , 1994	34989
@NP	Schnell	34989
@NP	et al. , 1994	34997
@NP	et al.	34997
@NP	1994	35005
@NP	The peculiar course	35012
@NP	a few regenerating fibres	35035
@NP	the caudal end of a capsule containing ECs	35080
@NP	the caudal end	35080
@NP	a capsule containing ECs	35098
@NP	a capsule	35098
@NP	ECs	35119
@NP	Fig. 4E	35136
@NP	an affinity between the nerve fibres and capsule	35162
@NP	an affinity	35162
@NP	the nerve fibres and capsule	35182
@NP	the nerve fibres	35182
@NP	capsule	35203
@NP	diffusible factors	35220
@NP	this behaviour	35264
@NP	future experiments	35308
@NP	Other controlling mechanisms	35328
@NP	our observations	35375
@NP	The fact	35393
@NP	only the group	35407
@NP	EC-injections	35436
@NP	a statistically significant increase	35463
@NP	the ratio of branches	35503
@NP	the ratio	35503
@NP	branches	35516
@NP	their corresponding control group	35544
@NP	ECs	35601
@NP	the inflammatory response	35624
@NP	the injury site	35653
@NP	One possibility	35670
@NP	the expression of inhibitory molecules such as chondroitin sulphate proteoglycan	35704
@NP	the expression	35704
@NP	inhibitory molecules such as chondroitin sulphate proteoglycan	35722
@NP	inhibitory molecules	35722
@NP	chondroitin sulphate proteoglycan	35751
@NP	Developmental studies	35786
@NP	an increase	35824
@NP	the polysialic acid level	35839
@NP	the neural cell adhesion molecule -LRB- NCAM -RRB- on CST axons	35868
@NP	the neural cell adhesion molecule -LRB- NCAM -RRB-	35868
@NP	the neural cell adhesion molecule	35868
@NP	NCAM	35903
@NP	CST axons	35912
@NP	the initiation	35937
@NP	collateral branching	35955
@NP	collateral	35955
@NP	Daston	35977
@NP	et al. , 1996 ; Joosten et al. , 1996	35984
@NP	et al.	35984
@NP	1996 ; Joosten et al.	35992
@NP	1996	35992
@NP	Joosten et al.	35998
@NP	Joosten	35998
@NP	et al.	36006
@NP	1996	36014
@NP	The cell adhesion molecule NCAM	36021
@NP	ECs both in vivo	36069
@NP	ECs both	36069
@NP	ECs	36069
@NP	vivo	36081
@NP	Chuah and Au , 1993 ; Miragall et al. , 1988	36100
@NP	Chuah and Au	36100
@NP	1993 ; Miragall et al.	36114
@NP	1993	36114
@NP	Miragall et al.	36120
@NP	Miragall	36120
@NP	et al.	36129
@NP	1988	36137
@NP	It	36144
@NP	our study	36167
@NP	NCAM expressed by encapsulated ECs	36178
@NP	NCAM	36178
@NP	ECs	36209
@NP	the capsule	36233
@NP	hence lesioned fibres	36250
@NP	stimulation	36301
@NP	the less exuberant collateral branching	36334
@NP	the less exuberant collateral	36334
@NP	Preliminary scanning electron microscopy	36375
@NP	encapsulated ECs retrieved from the spinal cord	36419
@NP	encapsulated ECs	36419
@NP	the spinal cord	36451
@NP	ECs	36478
@NP	a mucoid material	36511
@NP	extracellular matrix	36555
@NP	the capsule	36598
@NP	regenerating fibres	36636
@NP	Survival of ECs in the spinal cord	36657
@NP	Survival	36657
@NP	ECs in the spinal cord	36669
@NP	ECs	36669
@NP	the spinal cord	36676
@NP	the exact extent of EC survival in the injured spinal cord	36701
@NP	the exact extent	36701
@NP	EC survival in the injured spinal cord	36721
@NP	EC survival	36721
@NP	the injured spinal cord	36736
@NP	several studies	36786
@NP	Nash et al. , 2002 ; Ramon-Cueto et al. , 1998 , 2000	36803
@NP	Nash et al.	36803
@NP	Nash	36803
@NP	et al.	36808
@NP	2002 ; Ramon-Cueto et al.	36816
@NP	2002	36816
@NP	Ramon-Cueto et al.	36822
@NP	Ramon-Cueto	36822
@NP	et al.	36834
@NP	1998 , 2000	36842
@NP	1998	36842
@NP	2000	36848
@NP	ECs	36870
@NP	the spinal cord	36897
@NP	a long period	36918
@NP	to 8 months	36936
@NP	implantation	36954
@NP	Ramon-Cueto et al. , 2000	36968
@NP	Ramon-Cueto	36968
@NP	et al.	36980
@NP	2000	36988
@NP	this study	36998
@NP	it	37010
@NP	some ECs	37030
@NP	the spinal cord	37057
@NP	5 weeks	37076
@NP	it	37112
@NP	most of them	37132
@NP	most	37132
@NP	them	37140
@NP	macrophages	37170
@NP	our study	37186
@NP	autofluorescence of macrophages	37197
@NP	autofluorescence	37197
@NP	macrophages	37217
@NP	Hoechstlabeled ECs	37265
@NP	most instances	37293
@NP	these two types of fluorescence	37308
@NP	these two types	37308
@NP	fluorescence	37327
@NP	DeLucia et al. -LRB- 2003 -RRB-	37372
@NP	DeLucia et al.	37372
@NP	DeLucia	37372
@NP	et al.	37380
@NP	2003	37388
@NP	a cell line of Hoescht-labeled ECs	37406
@NP	a cell line	37406
@NP	Hoescht-labeled ECs	37421
@NP	macrophages or microglia 2 weeks following transplantation	37485
@NP	macrophages or microglia	37485
@NP	2 weeks	37510
@NP	transplantation	37528
@NP	recent experiments on encapsulated ECs in the spinal cord	37548
@NP	recent experiments	37548
@NP	ECs in the spinal cord	37583
@NP	ECs	37583
@NP	the spinal cord	37590
@NP	we	37607
@NP	the ECs	37626
@NP	the capsules	37645
@NP	growth-promoting molecules	37682
@NP	neuregulins -LRB- Woodhall et al. , 2003 -RRB-	37717
@NP	neuregulins	37717
@NP	Woodhall	37730
@NP	et al. , 2003	37739
@NP	et al.	37739
@NP	2003	37747
@NP	Real time	37754
@NP	quantitative RT-PCR performed on encapsulated ECs retrieved from the spinal cord	37764
@NP	quantitative RT-PCR	37764
@NP	encapsulated ECs retrieved from the spinal cord	37797
@NP	encapsulated ECs	37797
@NP	the spinal cord	37829
@NP	the expression profile of the various isoforms of neuregulins	37857
@NP	the expression profile	37857
@NP	the various isoforms of neuregulins	37883
@NP	the various isoforms	37883
@NP	neuregulins	37907
@NP	response	37930
@NP	the novel CNS environment	37942
@NP	it	37993
@NP	ECs injected into the spinal cord	38022
@NP	ECs	38022
@NP	the spinal cord	38040
@NP	ECs	38068
@NP	hence the fluorescent label	38102
@NP	Preliminary experiments in our laboratory	38162
@NP	Preliminary experiments	38162
@NP	our laboratory	38189
@NP	ECs	38214
@NP	increased proliferation	38226
@NP	spinal cord tissue	38266
@NP	Another reason	38286
@NP	the conditions influencing migration of ECs in the spinal cord	38309
@NP	the conditions	38309
@NP	migration of ECs in the spinal cord	38336
@NP	migration	38336
@NP	ECs in the spinal cord	38349
@NP	ECs	38349
@NP	the spinal cord	38356
@NP	It	38400
@NP	ECs	38426
@NP	the vicinity of the lesion	38466
@NP	the vicinity	38466
@NP	the lesion	38482
@NP	they	38510
@NP	signals from injured neurons -LRB- Boruch et al. , 2002 -RRB-	38536
@NP	signals	38536
@NP	injured neurons -LRB- Boruch et al. , 2002 -RRB-	38549
@NP	injured neurons	38549
@NP	Boruch	38566
@NP	et al. , 2002	38573
@NP	et al.	38573
@NP	2002	38581
@NP	a study in which the medial longitudinal fasciculus was transected	38600
@NP	a study	38600
@NP	the medial longitudinal fasciculus	38617
@NP	ECs	38668
@NP	the lesion -LRB- Gudino - Cabrera et al. , 1999 -RRB-	38706
@NP	the lesion	38706
@NP	Gudino	38718
@NP	Cabrera et al. , 1999	38726
@NP	Cabrera	38726
@NP	et al.	38734
@NP	1999	38742
@NP	The resolution of the fate and migratory behaviour of ECs in the spinal cord	38749
@NP	The resolution	38749
@NP	the fate and migratory behaviour of ECs in the spinal cord	38767
@NP	the fate and migratory behaviour	38767
@NP	ECs in the spinal cord	38803
@NP	ECs	38803
@NP	the spinal cord	38810
@NP	they	38855
@NP	a clinically relevant therapeutic agent	38885
@NP	Acknowledgments This work	38927
@NP	Acknowledgments	38927
@NP	This work	38943
@NP	the Motor Accident and Insurance Board -LRB- MAIB -RRB- of Tasmania	38967
@NP	the Motor Accident and Insurance Board -LRB- MAIB -RRB-	38967
@NP	the Motor Accident and Insurance Board	38967
@NP	MAIB	39007
@NP	Tasmania	39016
@NP	International Institute for Research in Paraplegia	39026
@NP	International Institute	39026
@NP	Research in Paraplegia	39054
@NP	Research	39054
@NP	Paraplegia	39066
@NP	the National Health and Medical Research Council	39081
@NP	the National Health	39081
@NP	Medical Research Council	39105
@NP	We	39131
@NP	Dr Jim Stankovich for advice on statistical analysis	39140
@NP	Dr Jim Stankovich	39140
@NP	advice on statistical analysis	39162
@NP	advice	39162
@NP	statistical analysis	39172
@NP	References	39195
@NP	2002	39306
@VP	promote collateral axonal branching in the injured adult rat spinal cord M.I.	29
@VP	branching in the injured adult rat spinal cord M.I.	55
@VP	revised 20 August 2003	321
@VP	has been used as an experimental strategy	468
@VP	been used as an experimental strategy	472
@VP	used as an experimental strategy	477
@VP	to promote regeneration of injured axons	510
@VP	promote regeneration of injured axons	513
@VP	transplanting encapsulated ECs with those injected directly into the spinal cord	599
@VP	encapsulated ECs with those injected directly into the spinal cord	613
@VP	injected directly into the spinal cord	641
@VP	filled capsules with ECs injected at the injury site	836
@VP	injected at the injury site	861
@VP	to label corticospinal neurons	1173
@VP	label corticospinal neurons	1176
@VP	were a few regenerating fibres , up to 10 , in the EC-treated groups	1239
@VP	received encapsulated ECs	1320
@VP	encapsulated ECs	1329
@VP	were present in close association with the capsule	1367
@VP	was observed in rats that received	1697
@VP	observed in rats that received	1701
@VP	received	1723
@VP	encapsulated ECs -LRB- P = 0.07 -RRB-	1732
@VP	is massive neuronal and glial cell death -LRB- Emery et al. , 1998 -RRB-	2021
@VP	been developed to alter this environment so that axonal repair can take place	2679
@VP	developed to alter this environment so that axonal repair can take place	2684
@VP	to alter this environment so that axonal repair can take place	2694
@VP	alter this environment so that axonal repair can take place	2697
@VP	can take place	2742
@VP	take place	2746
@VP	is the use of olfactory ensheathing cells -LRB- ECs -RRB-	2771
@VP	demyelinated axons -LRB- Li et al. , 1997 ; Imaizumi et al. , 1998 -RRB-	3057
@VP	is	3142
@VP	have undergone complete transection	3208
@VP	undergone complete transection	3213
@VP	operate in the novel environment of the injured spinal cord	3346
@VP	can be attributed to these soluble growth factors	3838
@VP	be attributed to these soluble growth factors	3842
@VP	attributed to these soluble growth factors	3845
@VP	is crucial for spinal cord repair	3942
@VP	encapsulated ECs with that of ECs injected directly into the injured spinal cord	4030
@VP	injected directly into the injured spinal cord	4064
@VP	was cut at T8	4150
@VP	cut at T8	4154
@VP	examining segments of the spinal cord rostral and caudal to the lesion	4240
@VP	are encapsulated or implanted directly into the spinal cord	4415
@VP	encapsulated or implanted directly into the spinal cord	4419
@VP	to examine the influence of ECs on collateral sprouting in the spinal cord	4518
@VP	examine the influence of ECs on collateral sprouting in the spinal cord	4521
@VP	sprouting in the spinal cord	4564
@VP	involving animals	4632
@VP	to increase the yield of ECs while maintaining a high level of purity	5043
@VP	increase the yield of ECs while maintaining a high level of purity	5046
@VP	maintaining a high level of purity	5078
@VP	were isolated from 3-day-old hooded Wistar rats euthanised in ice	5162
@VP	isolated from 3-day-old hooded Wistar rats euthanised in ice	5167
@VP	euthanised in ice	5210
@VP	was peeled away from the glomerular and deeper layers of the olfactory bulb	5237
@VP	peeled away from the glomerular and deeper layers of the olfactory bulb	5241
@VP	cutting away the surrounding respiratory tissue	5378
@VP	triturated	5916
@VP	filtered through a sterile nylon gauze -LRB- 80 Am pore size -RRB-	5928
@VP	Am pore size	5971
@VP	centrifuged for 10 min at 500 x g.	5989
@VP	were plated in CM	6042
@VP	plated in CM	6047
@VP	to minimise the population of fibroblasts	6163
@VP	minimise the population of fibroblasts	6166
@VP	Purified	6206
@VP	scraped from 25-cm2 flasks -LRB- Sarstedt , NC -RRB-	6334
@VP	centrifuged at 500 x g	6377
@VP	resuspended in CM	6404
@VP	loading	6601
@VP	sealed to form a capsule measuring 6 -- 8 mm long and containing about 105 ECs	6641
@VP	to form a capsule measuring 6 -- 8 mm long and containing about 105 ECs	6648
@VP	form a capsule measuring 6 -- 8 mm long and containing about 105 ECs	6651
@VP	measuring 6 -- 8 mm long and containing about 105 ECs	6666
@VP	measuring 6 -- 8 mm long	6666
@VP	containing about 105 ECs	6692
@VP	contained CM alone with no ECs	6735
@VP	transplanting to the spinal cord the following day	6844
@VP	were prelabeled with Hoechst 33342	7015
@VP	prelabeled with Hoechst 33342	7020
@VP	were growing in a 25-cm2 flask	7094
@VP	growing in a 25-cm2 flask	7099
@VP	incubated in 10 ng/ml Hoechst 33342 in CM	7130
@VP	diluted from a stock of 10 mg/ml in dimethyl sulfoxide	7176
@VP	incubated for 40 min at 37 °C	7247
@VP	washed four times in MEMH	7277
@VP	returned to fresh CM	7307
@VP	scraped off the flask	7357
@VP	viewed under ultraviolet filter to check that the staining had been successful	7383
@VP	to check that the staining had been successful	7415
@VP	check that the staining had been successful	7418
@VP	had been successful	7442
@VP	been successful	7446
@VP	to test whether any unincorporated Hoechst dye had remained in the solution	7505
@VP	test whether any unincorporated Hoechst dye had remained in the solution	7508
@VP	dye had remained in the solution	7548
@VP	had remained in the solution	7552
@VP	remained in the solution	7556
@VP	was incubated overnight with this medium and checked under ultraviolet filter	7615
@VP	incubated overnight with this medium and checked under ultraviolet filter	7619
@VP	incubated overnight with this medium	7619
@VP	checked under ultraviolet filter	7660
@VP	was observed	7737
@VP	observed	7741
@VP	dye in solution during the process of injecting ECs into the spinal cord	7860
@VP	injecting ECs into the spinal cord	7898
@VP	scraped from half the flask	7976
@VP	centrifuged at 500 x g	8005
@VP	resuspended at a concentration of about 104 cells/µl CM	8032
@VP	weighing 270	8124
@VP	were anaesthetised with 3 % isoflurane with oxygen	8143
@VP	anaesthetised with 3 % isoflurane with oxygen	8148
@VP	was removed with clippers	8705
@VP	removed with clippers	8709
@VP	swabbed with 70 % ethanol and povidone-iodine	8740
@VP	was incised and retracted	8908
@VP	incised and retracted	8912
@VP	were cut	8986
@VP	cut	8991
@VP	retracted	9011
@VP	performed using a dental drill and rongeurs to expose the dorsal spinal cord	9102
@VP	using a dental drill and rongeurs to expose the dorsal spinal cord	9112
@VP	to expose the dorsal spinal cord	9146
@VP	expose the dorsal spinal cord	9149
@VP	was incised with microscissors	9189
@VP	incised with microscissors	9193
@VP	include the dCST	9247
@VP	cutting twice	9399
@VP	was 1.5 -- 2.0 mm , centred on the midline	9435
@VP	centred on the midline	9451
@VP	produced a consistent total transection of the dCST on both sides	9553
@VP	suspended in CM or CM	9778
@VP	mounted on a stereotaxic frame	10000
@VP	were 1.0 mm deep to the dorsal surface of the spinal cord	10260
@VP	were selected to place the injected material just lateral to the dCST	10337
@VP	selected to place the injected material just lateral to the dCST	10342
@VP	to place the injected material just lateral to the dCST	10351
@VP	place the injected material just lateral to the dCST	10354
@VP	was injected at 1 µl/min at the injury site on the midline	10440
@VP	injected at 1 µl/min at the injury site on the midline	10444
@VP	was left in place for 1 min	10546
@VP	left in place for 1 min	10550
@VP	filled with CM	10622
@VP	centred anteroposteriorly on the injury site	10700
@VP	centred anteroposteriorly on the injury site	10984
@VP	were sutured with 5	11145
@VP	sutured with 5	11150
@VP	closed with Michel wound clips	11185
@VP	was swabbed with povidone-iodine	11226
@VP	swabbed with povidone-iodine	11230
@VP	returned to its individual home cage under a heat lamp for 1 h.	11271
@VP	To anterogradely label the corticospinal tract	11483
@VP	anterogradely label the corticospinal tract	11486
@VP	projecting to the lumbosacral enlargement of the spinal cord	11689
@VP	weighing 340 -- 365 g -LRB- n = 4 -RRB-	11882
@VP	removed with clippers	12137
@VP	swabbed with 70 % ethanol and povidone-iodine	12170
@VP	incised	12220
@VP	were retracted	12241
@VP	retracted	12246
@VP	cleared from the skull with cotton tip applicators	12267
@VP	were levelled in the horizontal plane by adjusting the bite bar	12341
@VP	levelled in the horizontal plane by adjusting the bite bar	12346
@VP	adjusting the bite bar	12382
@VP	coordinates relative to the bregma	12486
@VP	controlled by an sp310i syringe pump	12996
@VP	was left in place for 1 min after each injection	13045
@VP	left in place for 1 min after each injection	13049
@VP	were filled with bone wax	13106
@VP	filled with bone wax	13111
@VP	closed with suture clips	13146
@VP	was swabbed with povidoneiodine	13181
@VP	swabbed with povidoneiodine	13185
@VP	returned to its individual home cage under a heat lamp for 30 min	13225
@VP	followed by 4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13631
@VP	were dissected and placed in cold 4 % buffered paraformaldehyde overnight	13756
@VP	dissected and placed in cold 4 % buffered paraformaldehyde overnight	13761
@VP	buffered paraformaldehyde overnight	13793
@VP	removed en bloc from the rest of the vertebral column	13869
@VP	cut into segments at levels indicated in Fig. 1A	13927
@VP	indicated in Fig. 1A	13955
@VP	were embedded in Tissue-TekR O.C.T.	14277
@VP	embedded in Tissue-TekR O.C.T.	14282
@VP	containing the capsule	14392
@VP	Am thickness	14433
@VP	were floated on water bath to remove O.C.T. compound	14592
@VP	floated on water bath to remove O.C.T. compound	14597
@VP	to remove O.C.T. compound	14619
@VP	remove O.C.T. compound	14622
@VP	were floated	14796
@VP	floated	14801
@VP	dislodged from the rest of the spinal cord tissue	14835
@VP	leaving an oval-shaped space in the spinal cord section	14886
@VP	allowed to dry for 1 h in the dark	14957
@VP	to dry for 1 h in the dark	14965
@VP	dry for 1 h in the dark	14968
@VP	coverslipped using DAKO fluorescent mounting medium	14996
@VP	using DAKO fluorescent mounting medium	15009
@VP	To prevent evaporation	15049
@VP	prevent evaporation	15052
@VP	drying of sections	15076
@VP	was used to seal the edges of coverslips	15108
@VP	used to seal the edges of coverslips	15112
@VP	to seal the edges of coverslips	15117
@VP	seal the edges of coverslips	15120
@VP	were performed with a fluorescence attachment	15176
@VP	performed with a fluorescence attachment	15181
@VP	To count the number of dCST fibres in transverse sections	15400
@VP	count the number of dCST fibres in transverse sections	15403
@VP	were enlarged to A4 size and printed	15466
@VP	printed	15495
@VP	was placed over the fluorescent tract	15527
@VP	placed over the fluorescent tract	15531
@VP	were marked off with a pen as the counting proceeded	15586
@VP	marked off with a pen as the counting proceeded	15591
@VP	proceeded	15629
@VP	were similarly captured and counted at a magnification of 450x	15683
@VP	captured and counted at a magnification of 450x	15698
@VP	was used for counting the number of axonal branches from the vCST fibres	15825
@VP	used for counting the number of axonal branches from the vCST fibres	15829
@VP	counting the number of axonal branches from the vCST fibres	15838
@VP	were examined at 400 magnification	15956
@VP	examined at 400 magnification	15961
@VP	branching directly from vCST fibres	16018
@VP	exemplified by branching shown in Fig. 4H	16058
@VP	branching shown in Fig. 4H	16073
@VP	shown in Fig. 4H	16083
@VP	was counted	16101
@VP	counted	16105
@VP	was also counted	16193
@VP	also counted	16197
@VP	extending from a single axon	16276
@VP	was restricted to the grey matter	16335
@VP	were conducted at the corresponding similar level	16403
@VP	conducted at the corresponding similar level	16408
@VP	were performed by a person blinded to the treatment group	16465
@VP	performed by a person blinded to the treatment group	16470
@VP	blinded to the treatment group	16492
@VP	presented in Figs. 6A and B.	16693
@VP	followed by multiple pair wise comparison -LRB- Tukey test -RRB-	16786
@VP	was considered statistically significant	16862
@VP	considered statistically significant	16866
@VP	were presented as mean F SEM	16912
@VP	presented as mean F SEM	16917
@VP	Dissected brain and spinal cord of rat	16964
@VP	indicate the levels at which the spinal cord is cut into segments	17011
@VP	is cut into segments	17056
@VP	cut into segments	17059
@VP	bracketed segment	17236
@VP	bracketed segment	17260
@VP	contains the lesion and was longitudinally serially sectioned	17278
@VP	contains the lesion	17278
@VP	was longitudinally serially sectioned	17302
@VP	serially sectioned	17321
@VP	bar = 1.5 cm	17347
@VP	= 1.5 cm	17351
@VP	showing the Fluororuby-labeled dorsal corticospinal tract	17429
@VP	bar = 0.8 mm	17494
@VP	= 0.8 mm	17498
@VP	shows a magnified image of the fibres of the vCST	17514
@VP	bar = 200 µm	17571
@VP	= 200 µm	17575
@VP	received EC or CM injections also	17750
@VP	had culture medium -LRB- CM -RRB- - containing capsules placed over the lesion	17784
@VP	containing capsules placed over the lesion	17808
@VP	placed over the lesion	17828
@VP	was no statistically significant difference among the treatment groups	17858
@VP	expressed as a percentage of fibres at the cervical level within each group	18021
@VP	survive 5 weeks post-lesion	18328
@VP	are presented as mean ± SEM	18362
@VP	presented as mean ± SEM	18366
@VP	constitutes the middle one-third of the section	18608
@VP	indicate the approximate locations from which Fig. 4 is obtained	18676
@VP	is obtained	18729
@VP	obtained	18732
@VP	bar = 2.5 mm	18773
@VP	= 2.5 mm	18777
@VP	containing lesion and capsule , 2 weeks after injection of Fluororuby	18841
@VP	marks the cavity which previously housed a capsule containing ECs	18923
@VP	housed a capsule containing ECs	18957
@VP	containing ECs	18974
@VP	has been displaced ventrally in the spinal cord	19035
@VP	been displaced ventrally in the spinal cord	19039
@VP	appears to be in the path of the	19087
@VP	to be in the path of the	19095
@VP	be in the path of the	19098
@VP	sectioned dorsal corticospinal tract	19120
@VP	projecting from the sides of the tract -LRB- asterisk -RRB-	19172
@VP	are visible at higher magnification	19222
@VP	bar = 800 µm	19265
@VP	= 800 µm	19269
@VP	indicates a fibre sprouting from the dorsal corticospinal tract -LRB- dCST -RRB-	19289
@VP	sprouting from the dorsal corticospinal tract -LRB- dCST -RRB-	19307
@VP	marked by asterisk in A.	19372
@VP	ends in an arborisation of fine sprouts	19407
@VP	bar = 300 µm	19454
@VP	= 300 µm	19458
@VP	overlying the EC-containing capsule	19532
@VP	bar = 250 µm	19575
@VP	= 250 µm	19579
@VP	running close to the ventral edge of the capsule -LRB- C -RRB- containing ECs	19623
@VP	containing ECs	19676
@VP	bar = 700 µm	19698
@VP	= 700 µm	19702
@VP	running close to the EC-containing capsule	19751
@VP	curving around its caudal edge	19795
@VP	bar = 180 µm	19935
@VP	= 180 µm	19939
@VP	injected with ECs and transplanted with capsule containing the culture medium	19993
@VP	injected with ECs	19993
@VP	transplanted with capsule	20015
@VP	containing the culture medium	20041
@VP	is observed coursing away from the caudal edge of the capsule	20095
@VP	observed coursing away from the caudal edge of the capsule	20098
@VP	coursing away from the caudal edge of the capsule	20107
@VP	bar = 400 µm	20164
@VP	= 400 µm	20168
@VP	confronted with aggregates of fluorescent cells , presumably macrophages	20245
@VP	bar = 150 µm	20324
@VP	= 150 µm	20328
@VP	received	20410
@VP	encapsulated ECs	20419
@VP	was located	20646
@VP	bar = 600 µm	20665
@VP	= 600 µm	20669
@VP	received encapsulated ECs	20747
@VP	encapsulated ECs	20756
@VP	are clearly observed in the ventral funiculus	20806
@VP	observed in the ventral funiculus	20818
@VP	projecting fibre -LRB- arrows -RRB- in the dorsal	20864
@VP	originates from the fibre network present in the grey matter	20914
@VP	bar = 800 µm	20982
@VP	= 800 µm	20986
@VP	labeled with Hoescht blue before implantation	21037
@VP	bar = 40 µm	21090
@VP	= 40 µm	21094
@VP	surrounded by aggregates of ECs prelabeled with Hoescht blue	21148
@VP	prelabeled with Hoescht blue	21180
@VP	inset	21284
@VP	inset	21345
@VP	is yellowish crystalloid in appearance	21352
@VP	are present near the injection site or ECs	21420
@VP	Am	21480
@VP	bar in inset = 125 µm	21490
@VP	are present near this injection site -LRB- asterisk -RRB-	21540
@VP	bar = 180 µm	21595
@VP	= 180 µm	21599
@VP	received EC injections	21760
@VP	received only culture medium -LRB- CM -RRB- injections	21847
@VP	containing CM	21937
@VP	was also inserted in the spinal cord	21951
@VP	inserted in the spinal cord	21960
@VP	received encapsulated ECs	22019
@VP	encapsulated ECs	22028
@VP	was not statistically significant -LRB- P = 0.07 -RRB-	22157
@VP	received EC injections with the one that received encapsulated ECs	22263
@VP	received encapsulated ECs	22304
@VP	encapsulated ECs	22313
@VP	received either EC injections or encapsulated ECs	22501
@VP	received either EC injections	22501
@VP	encapsulated ECs	22534
@VP	terminating fibres in the grey matter caudal to the lesion	22588
@VP	are presented as mean ± SEM	22653
@VP	presented as mean ± SEM	22657
@VP	produced intense labeling of the corticospinal tracts -LRB- Fig. 1B -RRB-	23139
@VP	were present in compact arrangement as two well-defined tracts	23396
@VP	were distributed diffusely over a wide area of the ventral funiculus	23562
@VP	distributed diffusely over a wide area of the ventral funiculus	23567
@VP	found occasionally a few corticospinal fibres	23716
@VP	usually numbering fewer than six on each side	23763
@VP	being present in the lateral funiculi , just ventral to the dorsal horns	23810
@VP	was counted in all groups at the cervical , upper and mid-thoracic levels	23968
@VP	counted in all groups at the cervical , upper and mid-thoracic levels	23972
@VP	received ECs	24257
@VP	encapsulated or injected	24271
@VP	were present at the mid-thoracic level	24297
@VP	received CM-containing capsules together with CM injections	24360
@VP	had the least number of fibres with 86 F 20 fibres at the mid-thoracic level	24420
@VP	received only a CM-containing capsule	24638
@VP	were labeled	24793
@VP	labeled	24798
@VP	suggests that a considerable proportion of dCST neurons still survive	24924
@VP	survive	24986
@VP	had caused some compression of the vCST	25597
@VP	caused some compression of the vCST	25601
@VP	directly apposed to the rostral tip of the capsule -LRB- Figs. 3 and 4A -RRB-	25735
@VP	observed emanating from the cut stump and sides of the dCST -LRB- Fig. 4B -RRB-	25877
@VP	emanating from the cut stump and sides of the dCST -LRB- Fig. 4B -RRB-	25886
@VP	were present in EC-treated rats	25996
@VP	were characterised by axonal varicosities	26219
@VP	characterised by axonal varicosities	26224
@VP	often closely apposed , running in a parallel direction , typical of dCST fibres	26275
@VP	running in a parallel direction , typical of dCST fibres	26298
@VP	received encapsulated ECs	26368
@VP	encapsulated ECs	26377
@VP	are not associated with the normal trajectory of the dCST	26537
@VP	associated with the normal trajectory of the dCST	26545
@VP	had ECs injected directly into the spinal cord	26622
@VP	injected directly into the spinal cord	26630
@VP	caudally projecting fibres	26793
@VP	extended as far as 10 mm distal to the caudal edge of the capsule	26820
@VP	had received ECs -LRB- encapsulated or injected -RRB-	27004
@VP	received ECs -LRB- encapsulated or injected -RRB-	27008
@VP	encapsulated or injected	27022
@VP	are distributed over a wide area in the ventral half of the spinal cord	27648
@VP	distributed over a wide area in the ventral half of the spinal cord	27652
@VP	received encapsulated or injected ECs	27743
@VP	encapsulated or injected ECs	27752
@VP	extended to the dorsal columns	27826
@VP	grew distally in the space originally occupied by the dCST -LRB- Fig. 4H -RRB-	27861
@VP	coursed through the grey matter	28045
@VP	injected or encapsulated	28111
@VP	distally projecting fibres in the dorsal	28143
@VP	were observed to originate from a network in the grey matter -LRB- Fig. 4I -RRB-	28215
@VP	observed to originate from a network in the grey matter -LRB- Fig. 4I -RRB-	28220
@VP	to originate from a network in the grey matter -LRB- Fig. 4I -RRB-	28229
@VP	originate from a network in the grey matter -LRB- Fig. 4I -RRB-	28232
@VP	as described in Figs. 4H	28313
@VP	was not observed in animals from both control groups	28344
@VP	observed in animals from both control groups	28352
@VP	injected directly into the spinal cord	28411
@VP	were prelabeled fluorescently with Hoescht blue -LRB- Fig. 5A -RRB-	28450
@VP	was difficulty in localising the cells 5 weeks posttransplantation	28515
@VP	localising the cells 5 weeks posttransplantation	28533
@VP	were present -LRB- Fig. 5C -RRB-	28678
@VP	inset	28908
@VP	overlapped	28967
@VP	could be a consequence of macrophages having phagocytosed dead ECs	29016
@VP	be a consequence of macrophages having phagocytosed dead ECs	29022
@VP	having phagocytosed dead ECs	29054
@VP	phagocytosed dead ECs	29061
@VP	observed to be clearly branching directly from the vCST	29202
@VP	to be clearly branching directly from the vCST	29211
@VP	be clearly branching directly from the vCST	29214
@VP	clearly branching directly from the vCST	29217
@VP	shown in Fig. 4H	29262
@VP	were also counted	29280
@VP	also counted	29285
@VP	was variability in the proportion of labeled fibres in the vCST	29334
@VP	are dispersed over a wider cortical region	29575
@VP	dispersed over a wider cortical region	29579
@VP	To normalize the data	29619
@VP	normalize the data	29622
@VP	damaged some of the branches of the vCST	30197
@VP	received injections of CM	30268
@VP	sustained additional acute injury	30294
@VP	had ECs injected into the vicinity of the lesion	30380
@VP	injected into the vicinity of the lesion	30388
@VP	to have more axonal branches than those which received CM containing capsules	30627
@VP	have more axonal branches than those which received CM containing capsules	30630
@VP	received CM containing capsules	30673
@VP	containing capsules	30685
@VP	branching	30753
@VP	did not differ among treatment groups -LRB- Fig. 6B -RRB-	30922
@VP	differ among treatment groups -LRB- Fig. 6B -RRB-	30930
@VP	were more fibre terminations in the two groups that received ECs	31020
@VP	received ECs	31072
@VP	had ECs injected into the vicinity of the lesion	31116
@VP	injected into the vicinity of the lesion	31124
@VP	had only 3.1 ± 0.7	31250
@VP	have compared the effect of	31297
@VP	compared the effect of	31302
@VP	encapsulated versus injected ECs on collateral axonal sprouting	31325
@VP	sprouting	31379
@VP	regeneration in the injured spinal cord	31393
@VP	branching from the intact vCST	31490
@VP	is significantly increased in the presence of ECs	31521
@VP	increased in the presence of ECs	31538
@VP	encapsulated and injected	31669
@VP	have been reported previously by other research groups	31726
@VP	been reported previously by other research groups	31731
@VP	reported previously by other research groups	31736
@VP	transplanted into the spinal cord following injury to dCST	31898
@VP	resulted in increased collateral branches from the vCST	31957
@VP	terminated in the grey matter or extended dorsally	32040
@VP	terminated in the grey matter	32040
@VP	extended dorsally	32073
@VP	caudally along the original path of the dCST	32095
@VP	has generally been overlooked in ECtransplantation studies	32184
@VP	been overlooked in ECtransplantation studies	32198
@VP	overlooked in ECtransplantation studies	32203
@VP	sprouting	32279
@VP	is particularly important in the accurate interpretation of results	32289
@VP	are traced to their origin	32378
@VP	traced to their origin	32382
@VP	may not be solely attributed to regenerating fibres	32471
@VP	be solely attributed to regenerating fibres	32479
@VP	solely attributed to regenerating fibres	32482
@VP	reported the presence of regenerating dCST fibres following EC transplantation	32567
@VP	regenerating dCST fibres following EC transplantation	32592
@VP	would most likely have labeled the vCST	32937
@VP	have labeled the vCST	32955
@VP	labeled the vCST	32960
@VP	was contused	33030
@VP	contused	33034
@VP	is indicative of regeneration	33254
@VP	conceded that some could be originating from the spared vCST	33295
@VP	could be originating from the spared vCST	33314
@VP	be originating from the spared vCST	33320
@VP	originating from the spared vCST	33323
@VP	is performed	33403
@VP	performed	33406
@VP	sprouting to fibres	33464
@VP	caudal to the lesion can not be entirely discounted	33484
@VP	can not be entirely discounted	33505
@VP	be entirely discounted	33512
@VP	sprouting from descending motor tracts to functional recovery	33578
@VP	descending motor tracts to functional recovery	33593
@VP	should not be underestimated -LRB- Murray and Goldberger , 1974 -RRB-	33640
@VP	be underestimated -LRB- Murray and Goldberger , 1974 -RRB-	33651
@VP	underestimated -LRB- Murray and Goldberger , 1974 -RRB-	33654
@VP	stepping abilities in locomotion -LRB- Schucht et al. , 2002 -RRB-	33986
@VP	sprouting from the vCST following lesion of the dCST	34091
@VP	correlated with the rats ' ability to retrieve food pellets	34144
@VP	to retrieve food pellets	34178
@VP	retrieve food pellets	34181
@VP	was subsequently injured	34216
@VP	subsequently injured	34220
@VP	was abolished -LRB- Weidner et al. , 2001 -RRB-	34262
@VP	abolished -LRB- Weidner et al. , 2001 -RRB-	34266
@VP	sprouting	34405
@VP	injected directly into the injury site , those that received encapsulated ECs	34454
@VP	received encapsulated ECs	34505
@VP	encapsulated ECs	34514
@VP	demonstrated a trend for increased branching -LRB- P = 0.07 -RRB-	34531
@VP	received EC injections was compared with the one that received	34608
@VP	was compared with the one that received	34631
@VP	compared with the one that received	34635
@VP	received	34662
@VP	encapsulated ECs	34671
@VP	sprouting by diffusible growth factors	34798
@VP	closely enveloping the caudal end of a capsule containing ECs	35061
@VP	containing ECs	35108
@VP	shown in Fig. 4E	35127
@VP	is suggestive of an affinity between the nerve fibres and capsule	35145
@VP	are involved in inducing this behaviour	35239
@VP	inducing this behaviour	35255
@VP	will need to be confirmed in future experiments	35279
@VP	need to be confirmed in future experiments	35284
@VP	to be confirmed in future experiments	35289
@VP	be confirmed in future experiments	35292
@VP	confirmed in future experiments	35295
@VP	could account for our observations	35357
@VP	account for our observations	35363
@VP	compared with their corresponding control group	35530
@VP	suggests that injected ECs	35578
@VP	injected ECs	35592
@VP	could have altered the inflammatory response at the injury site	35605
@VP	have altered the inflammatory response at the injury site	35611
@VP	altered the inflammatory response at the injury site	35616
@VP	branching	35966
@VP	expressed by encapsulated ECs	36183
@VP	encapsulated ECs	36196
@VP	was isolated within the capsule	36213
@VP	isolated within the capsule	36217
@VP	accounting for the less exuberant collateral branching	36319
@VP	branching	36364
@VP	retrieved from the spinal cord	36436
@VP	suggesting that secreted extracellular matrix may be trapped within the capsule	36530
@VP	secreted extracellular matrix	36546
@VP	may be trapped within the capsule	36576
@VP	be trapped within the capsule	36580
@VP	trapped within the capsule	36583
@VP	can not be accessed by regenerating fibres	36614
@VP	be accessed by regenerating fibres	36621
@VP	accessed by regenerating fibres	36624
@VP	has yet to be quantified	36760
@VP	to be quantified	36768
@VP	be quantified	36771
@VP	quantified	36774
@VP	will have died in the spinal cord by 5 weeks post-implantation	37039
@VP	have died in the spinal cord by 5 weeks post-implantation	37044
@VP	died in the spinal cord by 5 weeks post-implantation	37049
@VP	is unlikely that most of them had been phagocytosed by macrophages	37115
@VP	had been phagocytosed by macrophages	37145
@VP	been phagocytosed by macrophages	37149
@VP	phagocytosed by macrophages	37154
@VP	could be clearly distinguished from Hoechstlabeled ECs	37229
@VP	be clearly distinguished from Hoechstlabeled ECs	37235
@VP	clearly distinguished from Hoechstlabeled ECs	37238
@VP	did not overlap	37340
@VP	overlap	37348
@VP	remained viable	37441
@VP	phagocytosed by macrophages or microglia 2 weeks following transplantation	37469
@VP	encapsulated ECs in the spinal cord	37570
@VP	survive in the capsules	37634
@VP	performed on encapsulated ECs retrieved from the spinal cord	37784
@VP	retrieved from the spinal cord	37814
@VP	changed in response to the novel CNS environment	37919
@VP	was difficult to localize ECs injected into the spinal cord	37996
@VP	to localize ECs injected into the spinal cord	38010
@VP	localize ECs injected into the spinal cord	38013
@VP	injected into the spinal cord	38026
@VP	may be that ECs continued to proliferate	38056
@VP	be that ECs continued to proliferate	38060
@VP	continued to proliferate	38072
@VP	to proliferate	38082
@VP	proliferate	38085
@VP	had been progressively diluted	38130
@VP	been progressively diluted	38134
@VP	show that ECs undergo increased proliferation when exposed to spinal cord tissue	38204
@VP	undergo increased proliferation when exposed to spinal cord tissue	38218
@VP	exposed to spinal cord tissue	38255
@VP	influencing migration of ECs in the spinal cord	38324
@VP	are not clearly understood	38372
@VP	clearly understood	38380
@VP	to migrate preferentially to the vicinity of the lesion	38437
@VP	migrate preferentially to the vicinity of the lesion	38440
@VP	be responding to signals from injured neurons -LRB- Boruch et al. , 2002 -RRB-	38519
@VP	responding to signals from injured neurons -LRB- Boruch et al. , 2002 -RRB-	38522
@VP	was transected	38652
@VP	transected	38656
@VP	are to be developed into a clinically relevant therapeutic agent	38860
@VP	to be developed into a clinically relevant therapeutic agent	38864
@VP	be developed into a clinically relevant therapeutic agent	38867
@VP	developed into a clinically relevant therapeutic agent	38870
@VP	thank Dr Jim Stankovich for advice on statistical analysis	39134
